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ABSTRACT
Tucker, Brian Christopher. M.S., Department of Neuroscience, Cell Biology and
Physiology, Wright State University, 2012. Glutamate receptor-mediated taurine release
from the hippocampus during oxidative stress.
Oxidative stress is an important result of cerebral ischemia and has been directly
linked to hippocampal swelling and cytotoxic brain edema in vitro. Swollen brain cells
activate volume regulatory mechanisms including a significant efflux of the endogenous
sulfonic amino acid taurine via volume-regulated anion channels (VRACs). Studies in
brain slice preparations also suggest that the excitatory amino acid glutamate plays an
important role in both brain tissue swelling and in cell volume regulation. We examined
relationships between oxidative stress, glutamate receptor activation, cell swelling, and
volume regulation in acutely prepared slices of rat hippocampus. Our results indicate that
the release of taurine from intracellular stores is critical for isoosmotic volume regulation
of the hippocampus exposed to oxidative stress. Further, taurine is lost from hippocampal
cells during oxidative stress via the volume activated anion channel (VRAC). The
glutamate AMPA receptors, and to a lesser extent NMDA receptors are coupled to
hippocampal swelling during oxidative stress. Our results further suggest volume
regulation of the hippocampus is regulated, in part, by glutamate signalling via NMDA
and AMPA receptors. Establishing the importance of taurine mobilization during
swelling induced by oxidative stress and presenting a significant role for glutamate
receptors in swelling and volume regulation is an important step in understanding the
cellular response to cytotoxic brain edema. Future work is needed to further our
understanding of the response and adaptation of brain cells to edema leading to improved
treatments and recovery from these devastating pathological conditions.
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CHAPTER I
INTRODUCTION

Brain edema is a common result of ischemic cardiovascular disease and is a major
contributing factor to the morbidity and mortality in ischemic cerebrovascular insults
including stroke and myocardial infarction [Klatzo et al. 1994; Plum et al. 1963].
However, current clinical treatments for brain edema address neither the cause of
increased water content nor the reactions of brain cells to swelling under ischemic
exposure. Further, the mechanisms used by brain tissue to regulate cell volume during
brain swelling remain largely unclear. A deeper understanding of the mechanisms
responsible for ischemia-induced brain edema will lead to improved treatment and
recovery from this devastating pathological condition.
It is understood that brain edema in ischemic and hemorrhagic stroke is associated
with the production of reactive oxygen species and consequent oxidative stress [Wagner
et al. 2000]. It is further observed that oxidative stress induces swelling in brain slice
preparations [Brahma et al. 2000], and that treatment with anti-oxidants can reduce
edema formation and brain damage following ischemia and reperfusion [Cuzzocrea et al.
2000; Daneyemez et al. 1999]. In response to swelling induced by either hypotonic or
oxidative stress conditions, brain slice preparations exhibit a significant efflux of the
organic osmolyte taurine. The efflux of this molecule during cell swelling occurs via
volume regulated anion channels (VRAC) [Saransaari et al. 2000; Pasentes-Morales et al,
2002]. Additional studies in brain slice preparations suggest that the excitatory amino
acid glutamate plays an important role in both brain tissue swelling, and in cell volume
regulation [MacGregor et al. 2003]. Glutamate also may modulate taurine efflux during
ischemia, [Saransaari et al. 1997] or may have an inhibitory effect on swelling in certain
cell types [Uckerman et al. 2006]. It has proven difficult to disentangle the related
2

processes of ischemia, oxidative stress, glutamate release, glutamate signaling, brain
edema, and taurine efflux. It is the goal of this project to elucidate some of these complex
relationships by examining glutamate signaling, tissue swelling and volume regulation in
brain slices exposed to oxidative stress.
The background of this manuscript will serve as the foundation of the project, and
will provide a detailed explanation of the previous research leading us to the hypothesis
and specific aims of the project. Because the experimental model used in this study to
induce brain edema is oxidative stress, the background will begin with a discussion of the
cellular redox environment and sources of reactive oxygen species (ROS). I will then
address both the pathological effects of oxidative stress and the physiological roles of
ROS including its effect on cell volume regulation. The second section of this
background will focus on the significant role taurine efflux plays for cell volume
regulation as it relates to regulatory volume decrease. I will outline the mobilization of
taurine during volumetric stress, and the significant role of volume regulated anion
channels (VRAC) in this process. Finally, this background section will discuss recent
studies that implicate glutamate as a significant mediator in ischemia-induced swelling
and cell volume regulation. A comprehensive understanding of oxidative stress, the role
of taurine efflux in cell volume regulation and the effects of glutamate on swelling and
volume regulation will prove helpful as we try to disentangle the complex relationships
between these inter-related processes.

3

CHAPTER II
BACKGROUND REVIEW
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1. Reactive Oxygen Species
Reactive oxygen species (ROS) can have either beneficial or deleterious effects
on the cellular environment. High concentrations of ROS elicit oxidative stress which can
cause structural damage to nuclear DNA, cell membrane degradation, lipid peroxidation,
protein dismutation and premature induction of apoptosis [Statdman et al. 1992; Evans et
al. 2004; Barros et al. 2001]. Oxidative stress has been implicated in many pathological
disease states ranging from Alzhiemer’s disease, amyotropic lateral sclerosis, diabetes,
heart attack, stroke and traumatic brain insult [Multhaup et al. 1997; Jackson et al. 1998;
Milam et al. 1998; Halliwell et al. 1989]. In contrast, moderate concentrations of ROS
have been found to play significant roles in many physiological signaling pathways and
processes such as immune response mediation, control of vascular tonicity, oxygen
sensing and induction of specific signal transduction pathways. This section will discuss:
(i) the cellular redox environment; (ii) the physiological production of ROS; (iii)
pathological ROS production and oxidative stress; (iv) the physiological role of ROS in
cellular signaling, control and function; and (v) the role of ROS on cell volume
regulation.
Physiological ROS Production- The Cellular Redox Environment
In mammalian physiology, energy is generated by the movement of electrons
from oxidizable organic molecules to molecular oxygen. Oxygen’s role in capturing
energy from metabolic substrates during aerobic respiration makes it essential for
survival. The efficient transfer of electrons to oxygen results in a chemically reducing
intracellular environment in which the production of reactive free radical species often
5

occurs [Schafer et al. 2001]. The unpaired electron of the free radical molecule gives it an
increased reactivity [Miller et al. 1990 Halliwell et al. 1989]. As a result, the term ROS
applies to a variety of oxygen-containing molecules which have increased reactivity due to their
unpaired electrons.

Traditionally, ROS have been regarded only as toxic by-products of metabolic
origin, with deleterious effects on lipids, proteins and DNA [Statdman et al. 1992].
However, current research indicates that ROS are essential participants in cellular
regulation and in specific intracellular signaling pathways [Valko et al. 2007]. Therefore,
a proper redox balance becomes significant in the effective regulation of these signaling
pathways. Redox balance is accomplished by a variety of antioxidant free radical
scavenging molecules. Anti-oxidant species such as superoxide dismutase (SOD),
catalase and glutathione neutralize potentially toxic ROS to remain within physiologic
levels. The relationship between antioxidant content and ROS production will determine
whether ROS is beneficial or deleterious within the cell [Thannickal et al. 2000].
Physiological ROS Production - Oxygen
Oxygen is the primary acceptor of electrons during oxidative phosphorylation of
aerobic respiration, and its ability to accept single electrons (see Equation 1) makes it the
most important class of radical species [Miller et al. 1990]. In accepting single electrons,
molecular oxygen is ‘reduced,’ making it a chemically strong oxidizing agent
[Thannickal et al. 2000]. The result is a partially reduced oxygen molecule, known as
superoxide radical (O2−) [Fruehauf et al. 2007].
O2

+ e−

= O2− (Superoxide Radical)
6

(1)

The single-electron reduction of O2 to its superoxide radical is created by both an enzyme
catalyst, and by ‘electron leaks’ between complex I and complex III of the electron
transport chain [Turrens et al. 2003, Kovacic et al. 2005]. The partially reduced
superoxide radical plays a significant role in ROS concentration for two reasons; it is
itself a free radical reactive oxygen species and it is the precursor to several other ROS
including H2O2, hydroxyl radical (OH.), hydroperoxyl radicals (ROO.) and peroxynitrate
radical (ONOO-) [Halliwell et al. 1999]. Thus, superoxide radical is an important
component in the development of oxidative stress conditions.
Superoxide radicals are produced by several intracellular sources, most notably
the electron transport chain, NADPH oxidase and xanthine oxidase. As a result of its
constant physiological production, the concentration of superoxide radical requires
constant regulation. The homeostatic regulation of superoxide radical is achieved by the
scavenging enzyme super oxide dismutase (SOD, see Equation 2). SOD is extremely
effective at catalyzing the reactive superoxide radical’s conversion to H2O2.
Mn+-SOD + O2− + 2H+ → M(n+1)+-SOD + H2O2.
where, M = Cu(n=1) ; Mn(n=2) ; Fe (n=2) ; Ni(n=2)
SOD is present in both the mitochondria and cytoplasm of cells. Mitochondrial
ROS contains manganese (MnSOD), is transcribed in the nucleus, and is localized to the
mitochondrial matrix. Cytoplasmic SOD is also transcribed in the nucleus but contains
copper and zinc (Cu/ZnSOD). The enzymatic action of SOD on superoxide radical is
diffusion limited, making it an extremely efficient antioxidant for this species.

7

(2)

SOD converts superoxide radical to H2O2, which is not a free radical species.
However, the increased concentrations of H2O2 lead to further ROS production, as it is
easily converted to the highly reactive and destructive hydroxyl radical. Hydrogen
peroxide can result in the production of hydroxyl radical via two different mechanisms.
The first mechanism is via the Fenton reaction, as H2O2 spontaneously reacts with Fe2+
(Equation 3).
Fe2+ + H2O2 → Fe3+ + OH· + OH− (Fenton Reaction)

(3)

Hydroxyl radical formation also occurs during the production of oxidized iron,
and involves a two step process (Equations 4 and 5). It is initiated via Habor-Weiss
reaction using an iron catalyst to reduce ferric ion to ferrous.
Fe3+ + •O2− → Fe2+ + O2 (Haber-Weiss Reaction)

(4)

The second step utilizes the above outlined Fenton reaction, and results in the
final production of the hydroxyl radical with the following net equation [Liochev et al.
2002].
•O2- + H2O2 → •OH + HO- + O2 (Net Equation)
Hydroxyl radicals are considered to be one of the most destructive forms of ROS,
resulting in irreversible lipid peroxidation, DNA damage, and protein oxidation [Pastor et
al. 2000]. Because of the toxicity of hydroxyl radical and the spontaneity of this
energetically favorable reaction, it must be closely regulated. This regulation is achieved
by two critical catalytic enzymes; catalase and glutathione. Catalase reacts with hydrogen
peroxide to catalyze the formation of water and oxygen (Equation 6) [Chelikani et al.
8

(5)

2004]. Catalase is highly concentrated near peroxisomes located in close proximity to the
mitochondria, a primary source for intracellular H2O2 production.
2 H2O2 → 2 H2O + O2 (Catalase Catalyst)

(6)

The second mechanism responsible for the decomposition of H2O2 involves
glutathione (GSH). Similar to catalase, glutathione contributes to the breakdown of H2O2
into water, although it utilizes a different mechanism (Equation 7). Glutathione acts as a
catalytic cofactor with other enzymes, such as glutathione peroxidase, as it detoxifies
hydrogen peroxide into water [Valko et al. 2007].
2GSH + H2O2 → GS–SG + 2H2O (Glutathione Peroxidase)
According to Dröge et al. 2002 reduced glutathione is considered the major redox
buffer within the cell and therefore acts as a representative indicator for the redox
environment of the cell [Dröge et al. 2002; Schafer et al. 2001]. consequently, nonreduced glutathione is abundant within the cytoplasm, and acts as a significant antioxidant in both the prevention and regulation of oxidative stress.
In addition to the ROS discussed above, additional reactive oxygen species found
in cells include organic hydroperoxides (ROOH), alkoxides (RO.) and peroxy radicals
(ROO.) [Thannickal et al. 2007]. There is also a subclass of reactive radical species
known as reactive nitrogen species (RNS). Like ROS, RNS contain one unpaired electron
on their outer orbital. While the mechanisms may be different, RNS behave in a very
similar manner as ROS, functioning in both physiological and pathological capacities.
Because this research centers on oxygen radical species, the specific reactions involving
9

(7)

these reactive radical nitrogen species and their antioxidant buffers will not be discussed
in detail. However, the importance of these radical species should be noted, as they play a
significant role in the state of the overall intracellular redox environment. As significant
contributors to total reactive radical (ROS/RNS) concentrations within the cell, RNS are
an integral component in free-radical homeostasis and cellular pathology, especially in
the development and regulation of oxidative stress.
Physiological ROS Production- Electron Transport Chain & ROS Production
There are numerous sources of intracellular ROS production. One major
physiological source is via mitochondrial oxidative phosphorylation in the electron
transport chain. Oxidative phosphorylation is the process by which ATP is produced by
the transfer of electrons from NADH and FADH2 to O2 in the inner mitochondrial
membrane. This occurs in a step-wise process as electrons are moved by electron
transporters through a series of specialized protein complexes. The protein complexes
within the inner mitochondrial membrane, known as Complex I, II, III and IV, have
specific roles in electron transfer. The individual complexes within the electron transport
chain make different contributions to the production of ROS.
The first protein complex in the electron transport chain is Complex I, the ‘NADH
ubiquinone oxidoreductase’ pathway. Complex I is the largest of the respiratory chain
components, consisting of a forty-six protein assembly, of which thirty-nine proteins are
nuclear encoded and the remaining seven are mitochondrial encoded [Grivenikova et al.
2001]. The electron donor in Complex I is NADH, from which two electrons are
transferred from NADH to ubiquinone within the mitochondrial membrane. As the two
10

electrons initially pass through Flavin Mononucleotide Phosphate (FMN), Iron-Sulfur
clusters and quinone, four protons are pumped out of the mitochondrial matrix into the
inter-membrane space [Ohnishi et al. 1985]. The final destination of the two donated
electrons is ubiquinone (UQ), which also acquires two additional protons, forming
ubiquinol (UQH2). Ubiquinol accumulates within the mitochondrial membrane, where it
then diffuses to Complex III, the next step in the electron transport chain [Metzler et al.
2001].
At complex II, the ‘Succinate-CoQ Reductase’ pathway, electrons are generated
by the oxidation of succinate. The conversion of succinate to fumarate is a reaction of the
tricarboxcylic acid cycle and is catalyzed by succinate dehydrogenase. During the
oxidation of succinate, electrons are delivered via FAD and Iron-Sulfur clusters into the
inner membrane where they interact with the ubiquinol, which serves as an electron
carrier. This accumulated reservoir of ubiquinol from Complex I and II within the inner
mitochondrial membrane serves as the electron source for Complex III.

The bio-chemical and physiological complexity of electron transfer in Complex I
and Complex II of oxidative phosphorylation have significant implications on the
superfluous production of ROS. Because ubiquinone acts as the electron transporter from
Complexes I and II to Complex III within the inner mitochondrial membrane, the stability
of the electrons attached to ubiquinone is vitally important. As ubiquinone shuttles
electrons from Complexes I and II to Complex III within the electron transport chain, the
potential for free radical production exists [Berg et al. 2006]. An incomplete reduction of
ubiquinone in Complex I generates ubisemiquinone radicals (UQH·), which are highly
11

reactive and quickly reduced by O2 ubiquinol (UQH2). If the highly reactive
ubisemiquinone radical is not reduced, it will react to form the highly oxidizing
superoxide radical, a predominant ROS contributing to oxidative stress. It is estimated
that between 1-3% of all oxygen entering the electron transport chain becomes partially
reduced to generate ROS as superoxide [Han et al. 2001; Lenaz et al. 2001].

The next step in the process involves Complex III, also called the ‘cytochrome c’
pathway. Complex III indirectly accepts the electrons from Complex I and Complex II by
accessing the electron rich pool of ubiquinol created within the inner mitochondrial
membrane. Due to its long hydrophobic tail, the reduced ubiquinol diffuses within the
lipid of the inner mitochondrial membrane, where the electrons are then donated to
Complex III. Within Complex III, electrons are transferred to various protein
components, first via iron-sulfur clusters to cytochrome c, and then onto cytochrome b.
While ubiquinol can carry two electrons, electron transfer occurs one electron at a time.
This transfer occurs during the 'Q-cycle,' as electrons are transferred from the twoelectron-carrying UQH2 to the single-electron carrying cytochrome-c (cyt-c) [Metzler et
al. 2001]. During this process, ubiquinol gives up its protons to the mitochondrial
intermembrane space (IMS). One of its electrons is carried through Fe-S clusters and cytc1 to cytochrome-c [Tian et al. 1998]. The second of its electrons is carried through two
cyt-b proteins and is re-distributed onto another ubiquinone molecule to form a
semiquinone radical. Similar to its production in Complex I, semiquinone radicals lead to
the formation of superoxide radicals. As a result, both Complex I and Complex III are
considered the primary contributors of ROS within the electron transport chain.
12

The final two components of the electron transport chain during mitochondrial
oxidative phosphorylation involve Complex IV and Complex V. Complex IV, also
known as cytochrome oxidase, acts as the final destination of the electrons transported
from Complexes I through III to oxygen. Complex IV receives its electrons from
cytochrome-c, which is a small, mobile protein that diffuses from complex III to complex
IV. The electrons are passed through a number of cytochrome-a and copper ion centers.
Cyt-a3 actually performs the reduction of oxygen to water. Each NADH originally
oxidized yields 2 electrons, enough to reduce half an O2 molecule to H2O. Therefore, two
NADH are necessary to reduce the entire O2 molecule to form H2O molecules.
Complex V, commonly referred to as ATP Synthase, converts the H+ gradient
created by the pumping of electrons during Complexes I thru IV, into ATP. ATP
production is driven by the H+ gradient created on the inner mitochondrial membrane and
the mitochondrial membrane potential. Collectively, these two driving gradient
components make up the proton-motive force responsible for ATP production [Alberts et
al. 1994]. Within Complex V, ATP synthase acts as a ‘rotor’ with its subunits rotating as
protons flow through. This creates conformational changes of the sub-units resulting in
the combination of ADP and inorganic phosphate to make ATP. However, in both
Complexes IV and V, there is little potential for partially reduced free radicals. As a
result, neither Complex IV nor Complex V are considered major contributors of ROS.

Physiological ROS Production- NADPH Oxidase
Another significant source of cellular ROS production is the six enzyme complex
NADPH-Oxidase. NAPDH-oxidase, also referred to as NOX, plays an important role in
13

host defense against microbes [Heyworth et al. 2003; Leto et al. 2006]. Phagocytes
including neutrophils, eosinophils and macrophages produce large amounts of
superoxide, with secondary production of other microbiocidal ROS [Knaus et al. 1991].
NOX consists of the catalytic subunit gp91phox, along with the regulatory
subunits p22phox, p67phox, p47phox, p40phox, and the small Rac-GTPase [Vignais et al.
2002; Nauseef et al. 2004]. P47phox, p67phox, p40phox and GTPase are cytosolic while
p22phox and the heme containing gp91phox are known to be membrane bound, and
considered integral membrane proteins [Vignais et al. 2002].
In the inactive state, the sub-units associated with the NADPH-oxidase complex
are dissociated. The individual sub-units of the NADPH-oxidase complex remain in an
inactivated dormant state until they are activated, usually by inflammatory mediators or
the presence of microorganisms. Interestingly, the protein sub-units of the NADPHoxidase complex remain dormant through an intricate series of auto-inhibitory
mechanisms [Kawahara et al. 2007]. In the resting cell, tandem domains on the cytosolic
p47phox complex remain bound together at an auto-inhibitory region (AIR), inhibiting it
from interacting with its membrane bound counterpart p22phox complex. Upon cell
activation, phosphorylation at the AIR releases the tandem p47phox binding domain,
exposing it so that it can then bind to p22phox [El Benna et al. 1994; Ago et al. 1999;
Groemping et al. 2003]. Through a complicated series of protein-protein interactions, the
binding domains of the remaining NOX components become exposed. These interactions
facilitate binding of cytosolic and membrane bound protein subunits to each other, and to
the membrane itself. As these subunits continue their integration, Rac-GTP translocates
to the binding domain of the membrane bound p67phox, activating the enzymatic action
14

of NADPH oxidase [Groemping et al. 2003]. In active NADPH oxidase, electrons are
transferred through two heme groups permitting reduction of molecular oxygen to the
superoxide radical at the gp91phox sub-unit, thus contributing to increased ROS
production.
Physiological ROS Production- Nitric Oxide Synthase
Nitric oxide synthase (NOS) is a highly regulated ROS producing enzyme with
contributions to a multitude of body systems. NOS serves as a significant source of ROS
production by catalyzing the synthesis of the free radical reactive nitrogen species nitric
oxide. There are several different NOS species, each distinguished by their function and
the unique manner in which they are regulated. NOS are classified as neuronal NOS
(nNOS), inducible NOS (iNOS) or endothelial NOS (eNOS). Each type is encoded by a
separate gene and although similar in structure, maintains uniquely specific functional
roles [Tylor et al. 1997].
The first iso-form of NOS was found in neuronal tissue, and is thus classified
nNOS, or NOS1. Bredt et al. 1999 established that the production of NO by nNOS in
nervous tissue occurs in both central and peripheral nervous systems. Within the CNS,
NO may mediate neuronal plasticity, implicating nNOS in the processes of learning and
memory [Bredt et al. 1999]. In the PNS, nNOS has a far reaching presence, where it is
found to contribute to NO production in the gut, macula densa in the kidneys, as well as
the urogenital tract [Baranano et al. 2001; Beierwaltes et al. 1997; Tomita et al. 1997].
Another species of NOS is endothelial NOS (eNOS), a calcium dependent NOS that
generates NO in blood vessels and thus regulates vascular function. In resting endothelial
cells, Fleming et al. 1999 established eNOS enzyme catalyses a sustained release of NO.
15

Further, eNOS is upregulated by several factors including activation of acetylcholine
receptors, or by shear stress [Staurt-Smith et al. 2002].
The final iso-form of NOS-generating enzyme, the calcium independent inducible
NOS (iNOS), has functional roles in immunity and inflammation [Mungrue et al. 2003].
Due to its functional role in host immunity, the activation of iNOS usually occurs in an
oxidative environment. In the presence of bacterial endotoxin, iNOS has been shown to
play a significant role in increasing NO concentration in macrophages, vascular smooth
muscle cells, and smooth muscle cells [Landry et al. 2001; Salkowski et al. 1997]. With
these resultant increases in NO concentration, and NO’s high affinity for ROS, there is
increased opportunity for reaction with superoxide radical [Stuart-Smith et al. 2002]. This
precipitates the formation of the reactive nitrogen species, peroxynitrite, one of the most
toxic classes of free radical species [Kanai et al. 2001].
While the regulation and function of each class of NOS species is unique, the
general role of all NOS enzymes is the synthesis of NO. At the molecular level, this
occurs on the nitrogen atom of L-arginine in the presence of NADPH and molecular
oxygen. NO is produced by carrying out a 5’-electron oxidation of the non-aromatic Larginine with the aid of tetrahydro-bioterin [Chinje et al. 1997]. This occurs via two
consecutive mono-oxygenation reactions forming N-hydroxy-L-arginine (NOHLA) as an
intermediate. During this two step reaction, electrons are transferred from NADPH to
O2.The final oxidation step forms the NO and L-citrulline products.
Of the three iso-forms, nNOS and eNOS are constitutive (cNOS), while iNOS is
considered to be inducible [Majano et al. 2001]. The nNOS and eNOS iso-forms are both
calcium dependent, as the intracellular Ca2+ concentration regulates the binding of
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calmodulin, which initiates the transfer of electrons from the flavins to the heme [Bredt et
al. 1999]. The iNOS, in contrast, acts independently of Ca2+, as calmodulin remains
attached to the iNOS iso-form regardless of Ca2+ concentration.
Physiological ROS Production – Peroxisomes
Peroxisomes act as another source of ROS production, particularly in the
contribution to total cellular H2O2. Peroxisomes are membrane bound organelles
important for intracellular metabolism, detoxification and protein transport [Bovaris et al.
1972]. Peroxisomes include a multitude of H2O2-generating enzymes including glycolate
oxidase, D-amino acid oxidase, urate oxidase, L-a-hydroxyacid oxidase and fatty acylCoA oxidase [Thannickal et al. 2000]. The H2O2 produced by these peroxisomal oxidases
has been found to oxidize a variety of substrates in additional “peroxisomal” reactions
[Tolbert et al. 1981]. These “peroxisomal” oxidative reactions play a significant role in
detoxification processes of ethanol in the kidney and liver cells, as well as in the βoxidation of fatty acids [Alberts et al. 1994]. Due to the downstream breakdown by
peroxisomal catalase, peroxisomal H2O2 concentrations usually remain within
physiological levels [Bovaris et al. 1972; Poole et al. 1975]. However, peroxisomal H2O2
production contributes to total cellular H2O2 concentration, implicating a potential role in
pathological ROS levels and oxidative stress. The effects of pathological ROS will be
discussed in more detail later in this background.
Physiological ROS Production- Xanthine Oxidase
Another intracellular source of ROS is xanthine oxidase. Xanthine oxidase is an
intracellular, membrane associated enzyme, responsible for catalyzing the oxidation of
hypoxanthine to xanthine. Xanthine oxide further catalyzes xanthine into uric acid, and is
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known to play a significant role in the catabolism of purines in humans [Harrison et al.
2002]. Xanthine oxidase is not considered to be a major source of ROS under
physiological conditions; however it becomes a contributor during periods of hypoxia,
hypoxia/reperfusion and oxidative stress [Dröge et al. 2002; Kayyali et al. 2001].
One of the unique characteristics of xanthine oxidase is the dynamic relationship
with its sister enzyme, xanthine dehydrogenase. Hille et al. 1995 established that,
depending on the method of purification, either dehydrogenase or oxidase can be
obtained from most intracellular sources. Further, for most mammalian systems, these
two enzymes can be reversibly converted by oxidation-reduction of cysteine residues
[Hille et al. 1995]. Xanthine oxidase can be converted to xanthine dehydrogenase by
reversible sulfhydryl oxidation which may occur in the presence of reducing agents like
dithiothreitol [Battelli et al. 1973]. The primary difference between the dehydrogenase
and the oxidase is the presence of an NAD+ binding site in the dehydrogenase indicating
xanthine dehydrogenase can reduce NAD+ [Hille et al. 2006]. Conversely, xanthine
oxidase does not have the NAD+ binding site, and instead appears to reduce molecular
oxygen. The reduction of molecular oxygen with xanthine oxidase results in the
formation of two types of ROS; H2O2, and superoxide radical [Harris et al. 1997]. The
production of superoxide radical by xanthine oxidase plays a role in several pathological
conditions, most notably hypoxia-reperfusion injury and the development of oxidative
stress [Parks et al. 1988].
Physiological ROS Production- Additional Sources
Most of the physiological production of ROS occurs during mitochondrial
oxidative phosphorylation in the electron transport chain by means of the catalytic
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enzymes NADPH, nitric oxide synthase and xanthine oxidase or within organelles such
as peroxisomes [Inoue et al. 2003]. Other sources of physiological ROS production
include processes in the endoplasmic reticulum and the nuclear membrane [Freeman et
al. 1982]. The endoplasmic reticulum plays an important role in lipid and protein
biosynthesis. Further, smooth ER contains enzymes that catalyze the detoxification of
lipid soluble drugs and other harmful metabolic by-products. Smooth ER contains p-450
and b-5 families of enzymes capable of oxidizing unsaturated fatty acids and further
reducing molecular oxygen to superoxide and H2O2 [Aust et al. 1972; Capdevila et al.
1981]. The nuclear membrane contains cytochrome oxidases with electron transport
systems similar to that of the ER, making it a potential site of ROS production [Thannikal
et al. 2000]. While their specific function is unknown, it has been postulated that these
enzyme systems exhibit “electron leaks” that precipitate ROS which are particularly
damaging to cellular DNA in vivo [Halliwell et al. 1989]. An additional, yet poorly
understood source of ROS is the auto-oxidation of catecholamines including epinephrine
and dopamine. The usual byproduct of such reactions is superoxide radical, which will
affect the overall cellular redox state, as well as the level of oxidative stress. Autooxidation of dopamine also may play a significant role in dopamine-induced apoptosis
[Ziv et al. 1997; Offen et al. 1998].
The discovery and understanding of the physiological contributors to ROS
production and redox regulation have developed greatly in the last four decades.
However, it is now increasingly evident that the physiological production of ROS reaches
farther than initially predicted, with even more significant physiological and pathological
consequences. Due to the large number of unique ROS species, and the complexity of the
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mechanisms that produce them, continued research on physiological ROS production is
essential to our understanding of oxidative stress.
Physiological Role of ROS- Cellular Signaling, Control and Function
ROS play a significant role in cellular communication, acting as a major
component in cell signaling and in signal transduction pathways [Poli et al. 2004]. Signal
transduction can be triggered by hormones, growth factors, cytokines and
neurotransmitters. In response to these stimuli, gene expression pathways are activated
through modulation of transcription factors [Fruehauf et al. 2007]. Activation of these
signaling pathways can induce many physiological processes including muscle
contraction, gene expression, cell proliferation/differentiation, apoptosis and nerve
transmission [Thannickal et al. 2000]. Further, exogenously applied H2O2 or increased
intracellular generation of H2O2 influences the function of various pathways, including
protein-tyrosine phoshatase/kinase signal transduction and activation of transcription
factors [Varela et al. 2004].
Over the past two decades, ROS have been discovered to play a significant role in
signal transduction pathways. Valko et al. 2006 explain that in response to cytokines,
growth factor and hormones most cell types elicit a “small oxidative burst” generating
increased concentration of ROS within the cell. This observation directly implicates ROS
as a secondary messenger in the signal transduction pathway and affecting the resulting
signal response cascade [Lowenstein et al. 1994].
A multitude of receptor ligands have been found to induce secondary ROS
production in non-phagocytic cells, including cytokines, growth factors and hormones.
Three of the first described and most widely recognized cytokines to induce secondary
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ROS production are TNF-α, IL-1 and IFN-y [Sundaresan et al. 1996]. As a result of the
secondary ROS production, TNF-α receptor may activate nuclear factor-αβ (NF-αβ) via
a ROS-dependent mechanism [Janssen-Heininger et al. 1999]. Further, according to work
by Tolbert et al. 1981, TNF-αβ-induced production of mitochondrial ROS has been
directly implicated in induction of apoptotic cell death. There also appears to be ROS
dependent TNF-α mechanisms involved in cell adhesion, production of chemokines and
IL-8 expression [Lakshminarayanan et al. 1997; Nakamura et al. 1998].
Interleukin-1 (IL-1) leads to secondary ROS production as a result of ligand
activation. In redox regulation, IL-1 functions in a manner similar to that of TNF-α
[Terry et al. 1999]. Studies by Lang et al. [1999] have shown that IL-1, TNF-α, and H2O2
induce insulin-like growth factor binding protein-1 synthesis in Hep G2 cells. Bonizzi et
al. 1999 also demonstrated several ROS-dependent pathways leading to NF-αβ activation
by IL-1B and Kheradmand et al. 1998 found that expression of collagenase by IL-1 may
be mediated by an autocrine loop involving Rac1, ROS and NF-αβ in fibroblasts
[Thannickal et al, 2000]. These studies indicate IL-1-induced ROS production plays a
significant role in signal transduction. In these and other experiments [Lo et al. 1998], the
activation of these pathways appears to be ROS dependent, implicating the essential role
of ROS as a signal transduction regulator in a multitude of cell processes, over a wide
range of cell types.
Another large class of cell surface receptors implicated in ROS-mediated
signaling is the receptor tyrosine-kinase (RTK) binding growth factors. Specific
mechanisms of growth factor induced ROS production and the consequent role of ROS
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(specifically H2O2) in secondary signal transduction are well documented in
contemporary reviews [Thannickal et al. 2000; Valko et al. 2007; Dröge et al. 2002].
However, EGF and PDGF serve as good examples of RTK receptors implicated in
downstream ROS/H2O2 dependent signal transduction. EGF increases intracellular Ca2+
concentrations in keratinocytes followed by ROS increase and PLA2 activation [Goldman
et al. 1997]. Further, EGF-generated ROS mediate ‘inhibitory cross talk’ with another
signal pathway activated by G-protein-coupled receptor [Zhang et al. 1999]. PDGF also
increases intracellular concentrations of H2O2, which is required for PDGF-induced
tyrosine phosphorylation, MAPK activation, DNA synthesis and chemotaxis [Sundaresan
et al. 1996]. Both EGF and PDGF also induce H2O2-dependent activation of p70(s6k)
that, through the up-regulated translation of mRNA transcripts encoding for components
of the protein synthetic machinery, is critical for cell cycle progression from G0/G1 to the
S phase [Bae et al. 1999]. Finally, exogenous H2O2 induces tyrosine phosphorylation and
activation of PDGF-a, PDGF-b and EGF [Gamou et al. 1995; Goldkorn et al. 1998].
These studies indicate that both endogenous and exogenous ROS, and more specifically
H2O2, are both capable of mediating specific components in signal transduction and
transcription pathways.
Additional ROS-generating kinase receptors include the TGF-b super-group of
serine/threonine kinase receptors. TGF-b1 stimulates ROS/H2O2 production in many cell
types [Islam et al. 1997; Kayanoki et al. 1994; Sanchez et al. 1996]. Shibanuma et al.
1994 demonstrated that TGF-b1-stimulated H2O2 production has a direct role in the
induction of early growth response-1 (egr-1) gene. In addition to these studies, work by
Shibanuma and others, indicates that TGF-b1 typically inhibits growth of most target
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cells [Das et al, 1992; Thannickal et al. 1995]. These studies establish the relationship
between TGF-b and growth inhibition, and outline a novel mechanism behind TGF-b1
induced H2O2 production. Extracellular catalase blocked both the TGF-b1-induced
increase in H2O2, and egr-1 growth gene expression. Thus, TGF-b1-stimulated H2O2
production may be generated predominantly extracellularly [Ohba et al. 1994]. BarcellosHoff et al. 1996 suggest that TGF-b1 may induce intracellular H2O2 production, which is
then released into the extracellular space before diffusing back into the cell. This concept
has implications on the potential effects of an increased extracellular H2O2 concentration,
specifically during periods of systemic oxidative stress. The results imply that if TGF-b1
stimulated pathways are up-regulated as a by-product of H2O2 diffusing into the cell, then
increased extracellular ROS via oxidative stress could also diffuse through the cell
membrane, pathologically affecting these downstream pathways.
G protein-coupled receptors are another class of cell surface receptors shown to
generate ROS in many mammalian cell systems. Some of the ligands responsible for G
protein-coupled-R stimulated ROS production are ANG-II, serotonin (5-HT), thrombin
and bradykinin [Alberts et al. 1994]. The physiological roles of ANG-II mediated by
secondary ROS include vasopressor activity [Rajagopalin et al. 1996], smooth muscle
cell hypertrophy [Zafari et al. 1998], induction of insulin-like growth factor-1 receptor
[Du et al. 1999], and IL-6 production [Kranzhofer et al. 1999]. Further studies suggest
that ANG-II stimulated H2O2 production elicits downstream consequences on the p38
family of MAPK pathways [Usio-Fukai et al. 1998]. 5-HT stimulates production of O2via several mechanisms, including activation of NADPH oxidase [Lee et al. 1999]. It
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appears, at least in part, that the 5-HT-induced superoxide radical exerts downstream
effects on the p42/p44 MAPK pathway, leading to cell proliferation [Lee et al. 1999].
Finally, ion channel-linked receptors induce ROS production. Ion channel-linked
receptors play an integral part in the nervous system, acting as ligand-gated channels that
mediate the synaptic transmission of information. Many ion channel receptor ligands are
neurotransmitters such as acetylcholine, 5-HT, glutamate and glycine. The relationship
between ion channel-linked receptors and the role of ROS in signal transduction is not as
well described as for other ROS-mediated receptor pathways. However, due to the
distinctive role of ion channel-linked receptors in the nervous system, there is interest in
the effects of neurotransmitter-induced ROS production, and its’ downstream role in
physiological cellular processes. For example, glutamate has been found to induce ROS
production in neuronal cells, and has been implicated as a key mediating factor in several
neuro-physiological processes including cell volume regulation [Morales et al. 2007].
The ability of ROS to function in specific cellular signaling pathways lies in their
unique properties of chemical reactivity. Superoxide radical (O2.-) and H2O2 have
specific biological targets, whereas hydroxyl radical (OH.) exhibits more indiscriminate
reactivity. This observation implies that ROS signaling molecules during normal
physiological conditions are more likely to utilize superoxide and H2O2 rather than
hydroxyl radical as secondary messenger molecules if the signaling pathway is specific in
nature.
Physiological Role of ROS- Mechanisms of ROS Signaling
ROS signals typically do not act as the primary agonist within signal transduction
pathways, but rather, as co-signals that allow integration and regulation of cellular
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activities. Acting as co-signals, or secondary messengers, ROS have been found to target
specific receptor pathways within the cell, as well as many of the MAPK pathways. For
example, MAPK pathways ROS (specifically H2O2) activates each signaling pathway in a
type and stimulus-specific manner [Valko et al. 2007].
IIes et al. [2002] found that endogenous production of H2O2 by a respiratory burst
specifically induces the MAPK-ERK (Extracellular-Regulated Kinase) pathways, but not
the MAPK-p38 kinase pathway. Conversely, exogenous H2O2 activates the MAPK-p38
pathway, while not inducing the MAPK-ERK activity in rat macrophages [IIes et al.
2002, Valko et al. 2007]. The significance of these observations lies in the difference
between the activated pathways. MAPK-ERK is a pathway typically associated with cell
proliferation, whereas MAPK-p38 pathway is associated more with cell differentiation
and apoptosis [Kyriakis et al. 2001]. Thus, the source of the ROS (i.e. intracellular vs.
extracellular) acting on the pathway is a significant determinant of which specific
receptor pathway becomes activated. This characteristic has significant implications in
physiological cell signaling processes, as well as in the differentiating role of ROS
signaling during periods of pathological oxidative stress.
As previously discussed, ROS have also been implicated as secondary messengers
mediating downstream activation of NF-αβ [Baud et al. 2001]. NF-αβ is one of the most
recognized classes of transcription factors associated with MAPK/ROS dependent
pathway activation [Thannickal et al. 2000; Valko et al. 2007; Dröge et al. 2002]. NF-αβ
is a transcription factor long considered to be oxidant responsive and regulates the
expression of a multitude of genes involved in cell survival, differentiation,
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inflammation, growth and immune response [Pande et al. 2005; Meyer et al. 1993;
Schreck et al. 1992].
Activator protein-1 (AP-1) is another class of transcription factor affected by
upstream ROS mediated signaling pathways. AP-1 is unique in that exogenous oxidants,
ligand-induced ROS and anti-oxidants have been implicated in AP-1 activation [Lo et al.
1995; Puri et al. 1995]. Further, according to Valko et al. [2007] AP-1 activity appears to
be induced in response to certain metals in the presence of H2O2, as well as other
cytokines, chemical and physical stresses. AP-1 appears to be activated as a stress
response in the regulation of cellular proliferation and apoptosis [Gabitta et al. 2000].
Physiological Role of ROS- Antioxidant Signaling
In addition to ROS, anti-oxidants play a physiological role in cellular signaling.
Because of the complex and dynamic nature of the redox environment within the cell,
any alteration of antioxidant activity would directly alter the efficacy of ROS-signaling
messengers. Therefore, the intracellular concentration of glutathione (GSH), the major
H2O2 redox buffer within the cell, has considerable implications on redox pathway
activation. GSH can play a role in blocking apoptosis and GSH depletion is observed
contemporaneously with the onset of apoptosis. A more reducing environment (regulated
in part by high levels of anti-oxidants like GSH) tends to stimulate cell proliferation,
while a slight shift towards oxidation initiates cell differentiation. Further intracellular
oxidation leads to apoptosis and necrosis with mild oxidizing stimuli leading to
apoptosis, while an intense oxidizing effect induces necrosis [Cai et al. 1998; Evans et al.
2004; Voehringer et al. 2000; Valko et al. 2007]. These observations not only indicate the
significance of the redox status within the intracellular signaling environment, but also
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implicate a potential role for GSH and other anti-oxidants as potential regulators in the
redox signaling environment.
In summary, ROS play important roles as secondary messengers, specifically in
the downstream regulation of cell proliferation, differentiation and apoptosis.
Concurrently, there is a burgeoning body of evidence implicating ROS in numerous other
cellular signaling pathways including: the mediation of immunological response of
lymphocytes [Bonizzi et al. 2000]; regulation of vascular tone [Lander et al. 1997];
sensing changes in oxygen concentration in the carotid body [Prabhakar et al. 2000];
regulation of erythropoietin production [Rancourt et al. 2010]; regulation of cell adhesion
properties [Roy et al. 1999]; and in the regulation of swelling-induced taurine efflux in
many cell lines [Lambert et al. 2004]. These processes are well summarized in
contemporary literature [Dröge et al. 2002; Valko et al. 2007; Thannickal et al. 2000].
Section two will discuss the role of ROS for the regulation of cell volume and its effect
on swelling-induced taurine efflux.
Pathological ROS Production - Oxidative Stress
Over-accumulation of ROS within the cellular environment may lead to the toxic
metabolic pathology of oxidative stress, an imbalance in pro-oxidant/antioxidant
concentrations. Elevated ROS concentrations can damage mitochondrial and nuclear
DNA [Evans et al, 2004] and cause lipid peroxidation, [Barros et al. 2001] inflammation,
[Lorgis et al, 2010], premature induction of apoptosis, [Malik et al. 2007] and aberrant
organismal aging [Khansari et al, 2009]. The effects of oxidative stress have been
implicated in diabetes, cancer, emphysema, arthritis, cataracts, atherosclerosis and
various other components of cardiovascular disease [Fruehauf et al. 2007]. Further,
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oxidative stress has more recently been implicated as a major contributor in
neurodegenerative disorders including Alzheimer’s disease [Multhaup et al. 1997],
Parkinson’s disease [Radunovic et al. 1997], Huntington’s disease [Mukherjee et al.
1997], ALS [Jackson et al. 1998], cytotoxic brain edema, and ischemia/re-perfusion
neuronal injuries [Milam et al. 1998]. The specific effects of oxidative stress on these
disease states are outlined comprehensively in contemporary literature [Thannickal et al.
2000]. For the purposes of this review, we will briefly discuss three major consequences
of oxidative stress following ischemia/reperfusion on cellular function including; DNA
damage and lipid peroxidation. The major point of discussion, however, will focus on the
pathology of oxidative stress as it relates to neuronal ischemia/reperfusion injuries and
cytotoxic brain edema.
Oxidative Stress – DNA Damage
Oxidative damage to DNA is a far reaching consequence of oxidative stress,
affecting both nuclear and mitochondrial DNA. Mitochondrial DNA is more susceptible
to oxidative damage due to its proximity to one of the primary sources of ROS, the
mitochondrial electron transport chain. Mitochondrial DNA also exhibits diminished
oxidative repair capacity compared to its nuclear counterpart [Finkel et al. 2000; Kregel
et al. 2007]. Some of the deleterious effects of DNA oxidation include nucleotide base
deletion and mutation, DNA-DNA cross linking, DNA-protein cross bridges, direct
oxidation of base pairs, and DNA strand breaks [Markesbery et al. 2007; Cadet et al.
1999]. The resulting modifications lead to aberrant physiological functioning of the cell,
including alterations in transcriptional and translational processes affecting cell survival,
apoptosis and senescence [Greer et al. 2005; Grishko et al. 2003; Hazra et al. 2007].
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The biochemistry of oxidative damage to DNA is unique, resulting from direct
interaction of ROS with the DNA strand structure. Unlike other damaging oxidative
stress mechanisms which are predominantly caused by peroxide and superoxide radicals,
oxidative DNA damage is caused primarily by hydroxyl radical. The reaction with DNA
occurs as the hydroxyl radical attacks the deoxyribose component of the DNA structure,
resulting in release of free bases from DNA and strand breaks [Hazra et al. 2007].
Oxidative Stress – Lipid Peroxidation
Because cell membranes contain a high concentration of poly-unsaturated fatty
acids, they are particularly susceptible to lipid peroxidation during oxidative stress
[Barros et al. 2001]. Poly-unsaturated fats contain multiple double bonds, thereby
creating an abundance of unstable and highly reactive hydrogens [Marnett et al. 1999].
During lipid peroxidation, free radicals abstract a hydrogen atom from the
polyunsaturated fatty acid moiety of membrane phospholipids, initiating a radicalmediated chain reaction [Sodergren et al. 2001]. The initial product is a new free radical
species on the fatty acid which then can propagate to an adjacent unsaturated moiety. As
the phospholipids of the cell membrane become compromised, the integrity of the cell
membrane is reduced and membrane fluidity is increased. The reaction continues until
termination, which can occur when two radicals react with each other [Dix et al. 1993].
The termination process is expedited by antioxidants like vitamin E, SOD, and catalase,
which can neutralize the reactive radicals and thereby protect the cell membrane from
further degradation [Porter et al. 2005; Cerutti et al. 1994]. Oxidation of cell membranes
is a significant mechanism leading to growth inhibition and cell death [Cerutti et al.
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1994]. Further, lipid peroxidation often triggers apoptosis, activating the intrinsic cell
death pathway present within cells [Sodergren et al. 2001].
Oxidative Stress – Ischemia-Reperfusion Injury
Oxidative Stress is a significant sequela of ischemia-reperfusion injuries
[Alexandrova et al. 2008]. Ischemia-reperfusion injuries occur from a prolonged period
of inadequate oxygen and metabolic substrate supply causing tissue ischemia, followed
by a period of reperfusion. The result of an ischemia-reperfusion episode is the initiation
of a wide array of inflammatory and metabolic disturbances that aggravate local injury
and impair healthy physiological organ function [Dorweiler et al. 2007]. Conditions
associated with ischemia-reperfusion injury include acute vascular occlusions like stroke,
and myocardial infarction; surgical procedures like organ transplantation, coronary
bypass and vascular surgery; and as a consequence of major metabolic trauma like
cerebral hemorrhage, near drowning and carbon monoxide poisoning [Choi et al. 1990].
Further, ischemia-reperfusion commonly results in increased ROS production, leading to
deleterious consequences associated with oxidative stress. Ischemia dramatically alters
oxygen metabolism within the cell and causes increased accumulation of ROS [Dorweiler
et al. 2007]. Under normal conditions, 95% of oxygen in mitochondrial respiration is
reduced to H2O without any free radical intermediates. The remaining 5% is reduced by
a univalent pathway in which free radicals like superoxide anion and H2O2 are produced
[Becker et al. 2004; Dorweiler et al. 2007; Han et al. 2001]. Under physiological
circumstances, these mitochondrial radical intermediates are safely metabolized to H2O
by dismutase, catalase and the glutathione peroxidase system. During periods of
ischemia, anti-oxidant defenses are compromised, allowing increased concentrations of
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H2O2 and the highly reactive hydroxyl radical [Becker et al. 2004] which damages
proteins and initiates lipid peroxidation [Granger et al. 1988].
In addition to a breakdown in anti-oxidant defenses during ischemia, there is also
a paradoxical increase in ROS production during ischemic hypoxia. Guzy et al. [2006]
found that the primary source of ROS production during hypoxia is complex III of the
electron transport chain. As a result of ischemia, when oxygen supply is limited, the
electron transport chain of the inner mitochondrial membrane becomes reduced, resulting
in oxygen radical production [Traystman et al. 1991]. Guzy et al. [2006], proposes that
the increased ROS production during hypoxia is the result of the lifetime of the reactive
ubisemiquinone radical in complex III, the tendency for mitochondrial ROS to be
released towards the matrix compartment as opposed to the inner-membrane space, and
the ability of O2 to access the ubisemiquinone radical in complex III [Guzy et al. 2006].
Further, Guzy et al. [2006] suggests that during hypoxia the electron transport chain acts
as an O2 sensor by releasing ROS into the intracellular environment. The ROS release
triggers several responses including activation of the hypoxia-inducible factor (HIF-1α)
[Turrens et al, 2003]. Because complex III is suggested to be a significant source of ROS
production during hypoxia, this implicates complex III as a possible source of oxidative
stress in ischemia/reperfusion injuries.
While hypoxia is established to cause an increase in ROS production, restoration
of oxygen during reperfusion also has been found to cause a significant increase in ROS
production [Dorweiler et al. 2007; Guzy et al. 2006; Traystman et al. 1991; Maxwell et
al. 1997].During the reperfusion stage of ischemia/reperfusion injuries, oxygen deprived
tissue becomes flooded with O2, causing downstream mitochondrial dysfunction and
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increased ROS production. In addition nitric oxide in the tissue reacts with the
increasingly prevalent superoxide radical to form peroxynitrite (ONOO-), which
dissociates into the extremely cytotoxic NO2 and OH- radicals. Further, there is increased
ROS production by xanthine oxidase following reperfusion. The specific mechanisms of
increased ROS production during reperfusion from these and other sources are discussed
in detail in contemporary literature [Chrissobolis et al. 2011]. These studies establish that
both ischemia and ischemia/reperfusion injuries cause a significant increase in ROS
production leading to oxidative stress.
Oxidative Stress- Brain Edema
Brain edema is a devastating pathological consequence of cerebral ischemiareperfusion injury [Dorweiler et al. 2007]. Consequent to ischemia-reperfusion, brain
edema is mediated, at least in part, by increased levels of ROS and oxidative stress
[MacGregor et al. 2003]. Because brain edema is the major contributing factor to
morbidity and mortality in stroke, understanding the interactions between ischemia,
oxidative stress and brain edema could have far reaching implications [Kasner et al.
2001; Steiner et al. 2001].
Fundamental to understanding the relationships between ischemia, oxidative
stress and brain edema is an understanding of post-ischemic brain edema formation. The
content of ATP in the brain is dependent on a continuous supply of energy and
approaches zero within approximately four minutes of complete ischemia [White et al.
1993]. As a result of ATP depletion, essential energy-dependent cellular mechanisms
begin to fail. As ion pumps cease to function, membrane ion gradients deteriorate,
selective and non-selective ion channels open, and intracellular and extracellular ions
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move towards their equilibrium causing membrane depolarization. During this anoxic
depolarization, potassium ions leave the cell while sodium, chloride, and calcium ions
enter. The loss of membrane ion gradients also decreases neuronal glutamate uptake
leading to exaggerated neuronal excitation and resulting additional sodium ion influx.
Consequently, intracellular osmolarity increases, causing neuronal swelling and the
development of cytotoxic brain edema. Cytotoxic brain edema is the first stage of
ischemic edema and occurs in the first five minutes of ischemia [Ozben et al. 1998].
During acute ischemic stroke, this initial edema is reversible and the blood-brain barrier
remains intact. However, after prolonged ischemia of several hours, the blood-brain
barrier becomes compromised and vasogenic brain edema develops. Vasogenic edema
causes death in one-third of insults and three-quarters of hemorrhagic brain insults
[Ozben et al. 1998]. The high mortality rate from vasogenic edema underscores the
importance of understanding and controlling brain edema in its early cytotoxic stage,
before the condition becomes irreversible and fatal.
The destruction of ion gradients, however, is not the only mechanism involved in
the development of post-ischemic brain edema. In addition, the increased ROS
production that occurs during ischemia and reperfusion can lead to brain edema both in
vitro, [Chan et al. 1982; Brahma et al. 2000] and in vivo [Oh et al. 1991; MacGregor et al.
2003] and has been associated with brain edema in ischemic and hemorrhagic stroke
[Deng et al. 2000; Wagner et al. 2000]. Studies have also shown that endogenous and
exogenous anti-oxidants reduce edema formation following ischemia-reperfusion, and
intracerebral hemorrhage [Deng et al. 2000; Nakamura et al. 2004]. Because tissue
ischemia has been found to increase ROS production [Deng et al. 2000], and increased
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ROS production has been found to precipitate brain edema [Chan et al. 1982], it can be
hypothesized that ischemia induced brain edema is mediated, at least in part, via a ROS
dependent mechanism.
Early studies by Chan et al. [1982] suggested that oxidative stress could induce
brain edema in brain tissue slices. Brahma et al. [2000] showed that brain slices incubated
in ascorbate, a prominent anti-oxidant in the brain, have diminished water accumulation
in vitro [Brahma et al. 2000]. We have observed brain tissue swelling induced by
oxidative stress in mouse hippocampal slices using 3-D microscopy similar to that shown
in swelling induced by hypoosmotic exposure [Figures 1 and Figure 2]. Further studies
show ROS scavenging agents (ascorbate, Trolox, dimethylthiourea, Tempol) significantly
attenuated ischemia induced water gain [Brahma et al. 2000]. These studies suggest
ROS play a significant role in brain edema formation.
Cell Volume Regulation
Cell volume regulation is essential for proper cell function and survival. To avoid
excessive alterations in cell volume, cells utilize several regulatory mechanisms. Because
mammalian cell membranes are highly permeable to water, the greatest factor affecting
cell volume is the osmotic gradient between the intracellular and extracellular
environments. Any alteration in either intracellular, or extracellular osmolarity will alter
cell volume. Cells exposed to a hypertonic extracellular environment will shrink, as water
flows down its chemical potential gradient from an environment of high chemical
potential inside the cell, to lower chemical potential outside the cell. Inversely, cells
exposed to a hypotonic environment will swell as water moves from the higher chemical
potential outside the cell, to the lower chemical potential inside the cell.
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Figure 1
Swelling induced by hypoosmotic exposure in hippocampal mice neurons Three-dimensional
confocal microscopy illustrates the effect of hypoosmotic (200 mOsm) exposure on stratum
pyramidal cell bodies in the CA1 area of mouse hippocampus in vitro. Three GFP-expressing
pyramidal cells in the CA1 layer show increases in cell volume within 15 min of exposure to
hypoosmotic aCSF. Confocal images were obtained at 1.5 µM intervals
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Figure 1
After 15 min
Baseline

Hypoosmotic Exposure
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Figure 2
Swelling induced by H2O2 exposure in hippocampal mice neurons Three-Dimensional
confocal microscopy illustrates the effect of oxidative stress on an individual GFP-expressing
pyramidal cell body in a mouse hippocampus. A pyramidal cell in the CA1 layer shows
significant increases in cell volume within 15 min of exposure to aCSF containing 2 mM H2O2.
Confocal images were obtained at 1.5 µM intervals.
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Cells generally regulate the direction of water flow across their plasma membrane
by manipulating intracellular or extracellular osmolarity. This occurs through
metabolism and transport of both inorganic (K, Na, Cl), and organic (taurine, alanine,
glycine, sorbitol, betaine, etc.) osmolytes into and out of the cell. There are two
prominent classes of volume regulatory mechanisms; regulatory volume increase (RVI),
which compensates for cell shrinkage; and regulatory volume decrease (RVD), which
compensates for cell swelling. RVI is well documented in contemporary reviews [Lang et
al. 1998; Wehner et al. 2003; Hoffman et al. 2009]. Recent studies have suggested that
ROS may play a significant role as an intracellular messenger in the mediation of RVD
[Lambert et al. 2003]. This background will focus primarily on RVD and the ROS
mediating signaling mechanisms involved in controlling RVD.
Cell Volume Regulation- The Role of ROS
ROS are produced in response to osmotic stress in several cell types [Varela et al,
2004] and are a mediating factor in swelling-induced activation and inactivation of the
volume-sensitive pathway for the release of the organic osmolyte taurine [Lambert et al.
2003, Lambert et al. 2008]. These experiments suggest ROS is a significant intracellular
signaling messenger during periods of osmotic stress, and more specifically as a mediator
of regulatory volume decrease.
Cellular swelling activates RVD mechanisms including the volume sensitive
outwardly rectifying Cl- channels (VSOR, also referred to as volume regulated anion
channel or VRAC in this background) in many cell types [Jackson et al. 1995]. While one
role of VRAC channels seems to be RVD, they are also involved in other physiological
processes including cell proliferation and apoptosis [Shen et al. 2000]. Recent studies
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have suggested ROS, specifically H2O2, can play a role in the activation of VRAC
channels [Varela et al. 2004]. In HTC cells, H2O2 (200 µM) in isotonic solution
reversibly activated outwardly rectifying Cl- currents. Thus, H2O2 can activate a Clcurrent, even in the absence of cell swelling. Further when HTC cells were exposed to
hypotonic solutions, a transient 15 fold increase in H2O2 concentration was observed
within the first 30 seconds of exposure. This increase in H2O2 production was reduced in
the presence of an NADPH-oxidase inhibitor. These results suggest that hypotonic
exposure induces H2O2 production, and that H2O2 production is generated, at least in part,
through an NADPH-oxidase dependent mechanism.
Similar studies by Lambert et al. [2002] also suggested that ROS play a mediating
role in regulatory volume decrease. H2O2 exposure potentiated swelling-induced taurine
efflux in NIH 3T3 fibroblasts during exposure to hypotonic medium, and the observed
taurine efflux was mediated via iPLA2 and 5-lipoxygenase (5-LO) signaling pathways.
Further studies by Lambert et al. [2008] indicate that the source of ROS involved in
iPLA2 mediated volume-sensitive taurine efflux pathway is NADPH-oxidase.
More recent studies by Friis et al. [2008] clarified the specific subtypes of
NADPH-oxidase involved in swelling-induced taurine efflux regulation. The unique
characteristics of the NADPH-oxidase complex of NIH 3T3 fibroblasts provide a system
for elucidating the specific components involved in osmotically induced NADPH-oxidase
ROS production, and related taurine efflux. NIH 3T3 fibroblasts express three NADPHoxidase components; p22 (a nox-4 iso-type), p47, and p67 [Friss et al. 2008], and appear
to release superoxide radicals from the NADPH-oxidase complex into the intracellular
compartment. Using this cell culture model, Lambert et al. [2003] and Friis et al. [2008]
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found that iPLA2 and 5-LO activity is required for swelling induced activation of taurine
efflux, ROS are produced by the NADPH-oxidase complex subsequent to PLA2
activation, the NOX-4 iso-type account for the swelling-induced increase in ROS
production in NIH3T3 cells, and ROS inhibit a protein tyrosine phosphatase (PTP1B)
causing a potentiation of swelling induced taurine efflux. Additional studies have further
established the role of ROS in RVD of several other cell types including HTC cells,
[Varela et al. 2004] and skeletal muscle cells [Ortenblad et al, 2003].
There is also new evidence that suggests ROS may regulate VRAC which
facilitate excitatory amino acid release in microglial cells [Harrigan et al. 2008].
Exogenously applied H2O2 increased swelling-activated glutamate release in microglia.
In addition, stimulation of microglia with zymosan, a treatment used to stimulate NOX
immune function, triggered production of endogenous ROS and increased glutamate
release via VRAC in swollen cells. Further, a significant efflux of D-aspartate (a nonmetabolizable analogue of glutamate) was observed upon H2O2 exposure, suggesting that
rat microglial VRAC are permeable to glutamate [Harrigan et al. 2008]. In addition to
establishing the role of NADPH-oxidase in mediating these microglial VRAC and the
subsequent effect on glutamate efflux, Harrigan et al. established that NOX-4 was the
probable source of endogenous ROS mediating VRAC activation and glutamate release.
In the present study, I will examine specific roles of both ROS and glutamate signalling
on cell volume regulation.
ROS Summary
ROS production and oxidative stress occur as a result of ischemia and ischemicreperfusion injuries and may cause brain tissue swelling in vivo. ROS also has a
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prominent role in cellular signaling, through a variety of mechanisms. More specifically,
ROS is a mediator of cell volume regulation via activation of VRAC in many cell types,
leading to taurine efflux during RVD. Because ROS can both initiate tissue swelling and
mediate cell volume regulation it plays an important role for brain edema development
consequent to oxidative stress. The present study will examine the role of ROS for brain
tissue swelling mediated by glutamate release as well as its role as a mediator of cell
volume regulation during oxidative stress.

2. Taurine
Taurine (2-aminoethanesulfonic acid) is a sulfonic amino-acid that functions in
many capacities including: neuromodulation of synaptic activity in the brain, induction of
neuronal hyper-polarization, inhibition of neuron firing, membrane stabilization and
neuro-development [Choe et al. 2012, Saransaari et al, 1992; Huxtable et al. 1992;
Kontro et al, 1983]. Taurine has been found to protect neurons against excitotoxicity and
prevent deleterious metabolic cascades induced by ischemic hypoxia [Schurr et al. 1987].
Taurine is one of the most abundant free amino acids in the brain, and has a concentration
higher than that of glutamate during certain developmental periods [Kontro et al. 1983;
Saransaari et al. 2006]. Dating back to Lange et al. [1963] taurine was introduced as a
component of osmo-regulation in marine animals. At present, taurine’s role in the central
nervous system is best understood as an osmolyte [Pasantes-Morales et al. 2002]. The
many roles of taurine in physiological and pathological function are well discussed in
published reviews and are out of the scope of this discussion [Wright et al. 1986;
Huxtable et al. 1992]. Rather, this discussion will focus on: (i) defining taurine structure
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and synthesis; (ii) examining mechanisms of taurine accumulation and release; (iii)
describing the role of taurine as an osmolyte for RVD; and (iv) evaluating neuroprotective effects of taurine related to glutamate toxicity. This discussion will unify the
major themes of the present project; oxidative stress, cell volume regulation, and the role
of glutamate on taurine mobilization during oxidative stress.
Taurine – Structure and Synthesis
Taurine is one of a handful of known naturally occurring sulfonic acids, and is
derived from the sulfhydryl amino acid, cysteine. Taurine is both a sulfonic acid and a
beta-amino acid, and unlike other amino acids which contain a carboxyl group, it
contains a sulfonate group. Some types of human cells can synthesize taurine from
cysteine via the cysteine sulfonic acid pathway. Via cysteine dioxygenase, the sulfhydryl
moiety of cysteine is oxidized to form cysteine sulfonic acid. Cysteine sulfonic acid is
then decarboxylated by sulfinoalanine decarboxylase forming hypotaurine. Finally,
hypotaurine is either spontaneously or enzymatically oxidized to yield taurine. Because
humans have some capacity to synthesize taurine, it is considered a conditional essential
amino acid. However, the majority of taurine in humans is acquired directly from food
sources [Wright et al. 1986].
Taurine – Cellular Accumulation
As a primary organic osmolyte involved in neuronal RVD, regulation of
intracellular taurine concentrations is of particular importance. Although several cell
types, including astrocytes, can synthesize taurine from cysteine, intracellular taurine
accumulation is primarily achieved through uptake by a specific membrane transporter
[Lambert et al. 2011]. Intracellular taurine content can reach millimolar concentrations
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[Beetsch et al. 1996]. The transporter responsible for mediating taurine uptake is a highaffinity, sodium and chloride ion dependent co-transport system. With this system, up to
three sodium ions are translocated with one chloride ion and one taurine molecule
[Beetsch et al. 1996; Wehner et al. 2003]. In the rodent brain, two distinct high affinity
carrier transporters have been identified, with each showing distinct regional and cellular
distribution characteristics [Pow et al. 2002]. Functionally, during periods of
hyperosmotic exposure, an increase in transporter mRNA and a concomitant increase in
the Vmax of taurine transporter contributes to increased intracellular taurine content
[Cammarata et al, 2002].
In addition to carrier mediated taurine transport, a diffusional transport
component can contribute to intracellular taurine accumulation [Takahshi et al. 2003].
This diffusion component may be mediated via passive taurine movement through anion,
or volume-sensitive organic osmolyte channels [Jackson et al. 1993]. The mechanisms of
taurine uptake indicate that maintaining proper intracellular taurine concentration is an
efficient and well regulated process. Further, these mechanisms underscore the
importance of taurine accumulation as a vital component in effective cell volume
regulation.
Taurine – Cellular Release
While accumulation of taurine seems to occur primarily by carrier-mediated
transport, taurine release appears to be mediated by several mechanisms including;
simple passive diffusion, carrier mediated transport, and exocytosis [Pasentes-Morales et
al. 2002]. Taurine diffusion through cell membranes is strictly driven by concentration
gradients, and exhibits non-saturable transport kinetics. The rate of taurine release via
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diffusion will depend on intracellular and extracellular taurine concentrations. In contrast,
carrier mediated release of taurine occurs via reversal of the uptake transporter. It is
sodium-dependent, exhibits saturation kinetics, and is subject to competitive inhibition by
structural analogs, such as alanine [Saransaari et al. 2000].
Taurine release via VRAC is regulated by volumetric stress [Saransaari et al.
2000]. The Cl- channels activated during hypo-osmotic swelling are typically outwardly
rectifying with an intermediate unitary conductance of 40-78 pS, with inactivating
potentials at +60 mV and above [Pasantes-Morales et al. 2002]. This volume sensitive Clchannel has been characterized in many brain cell types including astrocytes, C6 glioma
cells, and in cerebellar and hippocampal neurons [Jackson et al. 1995; Li and Olson 2008;
Patel et al. 1998]. VRAC exhibit high selectivity of anions over cations, permeability to
most monovalent anions, and a broad anion selectivity [Pasantes-Morales et al. 2002].
Enhanced activation of VRAC channels has been shown in the presence of ATP,
indicating purinergic receptors may be involved in the mediation of VRAC activity
during volume regulation [Mongin et al. 2002; Li et al. 2004]. Li et al. [2004]
demonstrated that volume regulatory efflux of amino acids, including taurine via VRAC,
is also dependent upon an elevated or permissive level of intracellular calcium and
calmodulin activation in astrocytes [Li et al. 2004]. Experimentally, VRAC mediated
taurine release can be used to indicate when mechanisms of RVD have been activated.
Specific mechanisms of VRAC activation during oxidative stress remain poorly
defined. As previously discussed, VRAC have been shown to be activated by ROS in
swollen microglia leading to increased release of excitatory amino acids [Harrigan et al.
2008]. However, because oxidative stress has been found to cause swelling in both neural
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tissues and cells, it is less clear if ROS can regulate VRAC in the absence of swelling. In
the present project, I will examine potential mechanisms linking oxidative stress and cell
swelling to VRAC activation and taurine release.
Taurine – Mobilization During Cell Volume Regulation
In brain tissue, in situ and in vitro studies indicate that taurine is the most
important osmotically active organic molecule involved in volume regulation during both
hypo-osmotic hyponatremia, and hyperosmotic dehydration [Verbalis et al. 1991;
Bedford et al. 1993]. Organic osmolytes, including taurine, are especially important for
brain volume regulation for two reasons; first, the brain is especially vulnerable to cell
volume alterations as a result of its rigid surrounding skull and dura structures and
second, unlike ions, organic osmolytes have limited affect on neuronal excitability and
are compatible with normal macromolecular function [Law et al. 1994]. Release of
inorganic electrolyte osmolytes such as K, Na, and Cl during cell volume regulation in
the CNS, would alter ion gradients across the cell membranes and thus affect ion
transporters, membrane polarization, and excitability [Law et al. 1994; Verbalis et al.
1991]. However, K, Na and Cl are lost from the brain during the first three hours of
hyponatremia, indicating these electrolytes play a significant role in the immediate
volume decrease response in the intact brain [Berl et al. 1990; Pasantes-Morales et al.
2002]. However, during periods of chronic hyponatremia, release of electrolytes
decreases over time [Verbalis et al. 1991] while cells activate release of osmotically
active organic solutes including polyalchohols, methyl amines and amino acids such as
taurine, glutamate, glutamine and glycine. According to Huxtabel et al. [1992] taurine
may be the ‘perfect osmolyte’ in the CNS because it is metabolically inert and exhibits
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only weak synaptic interaction [Huxtabel et al. 1992]. Further, taurine as well as other
organic osmolytes are often referred to as ‘compatible osmolytes’ based on the concept
that they do not perturb cellular macromolecules even when the solutes are at high
concentrations [Yancey et al. 2005; Brown et al. 1972]. Thus, the use of taurine and other
organic osmolytes for volume regulation, allows cells to circumvent the deleterious
effects of altered ion concentration disturbances, without compromising other vital cell
functions [Bagnasco et al. 1993; Burg et al. 1994, Lang et al. 1998].
The average intracellular taurine concentration in adult human cells is between 26 mM and even higher for many neurons, including cerebellar Purkinje cells and
hippocampal pyramidal cells [Banay-schwartz et al. 1993; Nagelhus et al. 1993; Pow et
al. 2002]. Exposure of brain tissue to hypoosmotic conditions causes a reduction in brain
taurine content by as much as 85% [Kimelberg et al. 1995; Verbalis et al. 1992]. Taurine
efflux is enhanced in both cerebral cortical slices, and hippocampal tissue slices exposed
to hypoosmotic conditions [Franco et al. 2000; Law et al. 1994]. Taurine also enhances
volume regulation in hippocampal slices swollen osmotically and during exposure to
oxidative stress in isoosmotic conditions [Kreisman et al. 2003]. These results indicate
that brain tissues exposed to hypoosmotic conditions utilize a release of intracellular
taurine, followed by the osmotically obliged water to facilitate regulatory volume
decrease [Haussinger et al. 1994; Kimelberg et al. 1995]. As a result, tissue cellular
swelling is reduced or eliminated and vulnerability to potential pathological
consequences of prolonged alterations in cellular volume are thereby reduced [Kimelberg
et al. 1995].
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While the above studies indicate taurine is released from cells in response to
hypoosmotic conditions, the redistribution of the taurine released during these conditions
is not well understood. Lehmann et al. [1991] suggested that some of the increase in
extracellular taurine in hippocampal tissue under hypoosmotic conditions may come
across the blood brain barrier. Solis et al. [1988] illustrated that during the early stages of
hypoosmotic hyponatremia, cells mobilize intracellular taurine contents into the
extracellular space [Solis et al. 1988]. Nagelhus et al. [1993] showed during the first hour
of hypo-osmotic hyponatremia, taurine contents of cerebellar Purkinje cells are reduced,
while the taurine contents of neighboring astroglial cells are increased. Further, early
studies dating back to the 60’s have observed a greater swelling of glial cells relative to
that of neurons during pathological conditions characterized by cytotoxic edema [Plum et
al. 1963; Klatzo et al. 1967; Betz et al. 1989]. More recent studies have demonstrated
that, in cell culture, taurine is preferentially lost from osmotically swollen neurons
compared with astroglial cells, and that swollen neurons rapidly down-regulate the
taurine transporter [Olson et al. 2000; Olson et al. 2006]. These studies suggest that
during pathological conditions characterized by brain edema, taurine is mobilized from
neurons, and into surrounding glia [Olson et al. 2006]. These observations may represent
a neuroprotective mechanism by which neurons and glial cells transport taurine to
minimize the effects of neuronal swelling on brain function, and potential downstream
consequences of chronic brain edema.
Taurine- Other neuroprotective mechanisms
The most well documented role of taurine in neuroprotection is its role in volume
regulation. However, studies indicate additional mechanisms by which taurine may act in
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a neurprotective capacity. Intracellular taurine protects neurons against glutamateinduced neuronal damage in primary neuronal culture. The neuroprotective effect of
taurine has been largely attributed to its functions in maintaining intracellular calcium
homeostasis, membrane integrity (Pasantes-Morales et al. 1984] and as an antioxidant
[Wu et al. 2009]. Further, Leon et al. [2009] proposed that taurine protects neurons
against glutamate-induced neurotoxicity in part, by preventing glutamate induced
membrane depolarization through inhibition of intracellular Ca2+ accumulation and
thereby inhibiting glutamate-induced apoptosis.
Taurine-Summary
The research discussed here indicates that taurine plays an important role in many
aspects of neuroprotection. Studies indicate taurine as a significant effector in
intracellular signaling pathways and illuminate an important neuroprotective role of
taurine in glutamate-induced neuronal damage. Further studies indicate that taurine plays
an integral role in cell volume regulation during both osmotically-induced and
oxidatively induced swelling [Kreisman et al. 2003; Li et al. 2004]. While research has
helped establish taurine as a significant factor in volume regulation in the CNS, the
mechanisms behind these effects remain largely unclear. In this work we will examine
taurine release from hippocampal tissue slices during exposure to H2O2. With this model
of exposure to oxidative stress, taurine release and volume will be measured under
different conditions including; during exposure to VRAC channel blockers, during
exposure to glutamate receptor antagonist and in conditions which inhibit tissue swelling.
By examining taurine release during these conditions we will clarify specific
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neuroprotective mechanisms of taurine as they relate to volume regulation during
oxidative stress.

3. Glutamate
Glutamate receptor activation has been suggested to be a factor in ischemiainduced brain edema [MacGregor et al. 2003]. Because glutamate plays a multi-faceted
role in the central nervous system, this review will include only a brief physiological
review of the role of glutamate as a neurotransmitter in the CNS, and the receptor subtypes involved in glutamate signaling in neurons and glial cells. After discussing the
physiological foundation of glutamate signaling in the CNS, this review will focus on
three central topics relevant to our study, (i) the increase in glutamate concentrations in
the CNS during tissue ischemia; (ii) the role of glutamate in the development of postischemic brain edema; and (iii) the role of glutamate receptors in cell volume regulation.
This background on glutamate will elucidate associations between oxidative stress, tissue
edema, glutamate receptor activation and cell volume regulation. This interaction is
central to the project hypothesis relating the role of glutamate receptors during
oxidatively induced brain edema.
Glutamate – Glutamate Signaling
Glutamate is the primary excitatory neurotransmitter in the central nervous
system. Nutritionally, it is classified as a non-essential amino acid, as it can be
synthesized from other molecules, primarily a-ketoglutarate and glutamine [Nicholis et
al. 1994]. The generation of glutamate from a-ketoglutarate occurs in the mitochondria in
an efficient one-step process. Glutamine is used in the synthesis of neuronal glutamate
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and is provided primarily by glial cells. An elementary physiological overview of the
synthesis, release, uptake and metabolism of glutamate in neurons and glial cells is
outlined below. Further, this review provides the foundation for understanding glutamate
metabolism during pathological conditions such as ischemia and oxidative stress.
Neurons use glutamate in many processes, most notably as an excitatory
neurotransmitter in the CNS. Glutamate is present in two metabolic pools within neurons.
Neurotransmitter glutamate is stored within synaptic vesicles and is compartmentalized
from non-neurotransmitter glutamate [Gonzales et al. 1997]. Glutamate signaling begins
as glutamate-containing vesicles fuse with the cell membrane, releasing their content into
the synaptic cleft. The next step in the signal transduction process involves the activation
of glutamate-specific receptors, inducing excitation of the post-synaptic neuron. The
process is terminated as the glutamate is transported via specific carrier proteins back to
the pre-synaptic neuron and to surrounding glial cells. Glutamate returning to the presynaptic neuron is transported and packaged directly into synaptic vesicles. Glutamate
transported into glial cells is rapidly converted by glutamine synthetase into glutamine,
where it then can be transported back into the pre-synaptic cell for conversion back to
glutamate. As a result, glial cells play two essential roles in glutamate signaling in the
CNS: terminating the glutamatergic synaptic signal and ensuring a sufficient supply of
pre-cursor glutamine for neuronal glutamate synthesis. The glutamate re-uptake system
of glial cells is indispensible for preventing excessive glutamate excitation of the postsynaptic neuron.
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Glutamate – Glutamate Receptor Sub-types in Neurons and Glial Cells
Glutamate receptors are the primary molecules involved in excitatory signal
transmission [Nakanishi et al. 1992]. The post-synaptic responses to glutamate are
mediated by two separate classes of receptors: ionotropic (iGlu) receptors and
metabotropic (mGlu). The iGlu classes of receptors are cation-specific ion channels
responsible for mediating fast excitatory transmission. There are three different families
of iGlu, which are defined by their respective pharmacological antagonist profile; aamino-3-hydroxyl-5-methyl-4-isoazoleproprionic acid (AMPA), kainate, and N-methylD-aspartate (NMDA).
The second class of glutamate receptors is a family of G-protein-coupled
receptors called mGlu. mGlu are found in both neurons and glia where they exert a
multitude of effects on glia function and provide a mechanism for glial-neuronal
interactions. The mGlu family is a seven transmembrane domain receptor that exerts its
effects on both ion channels and on secondary messenger systems. There are eight
different sub-types of mGlu receptors (mGlu1-8), differentiated by agonist
pharmacology, signal transduction pathways, and sequence homology [D’antonio et al.
2008]. mGlu receptors modulate synaptic transmission, including the processes
responsible for long-term potentiation and long-term depression. In neurons, mGlu1 and
mGlu5 receptors modulate post-synaptic efficacy, whereas mGlu2, mGlu3, mGlu4,
mGlu7 and mGlu8 are mainly pre-synaptic and regulate neurotransmitter release
[Ferragutti et al. 2006]. The specific structures and functions of mGlu receptor sub-types
are well discussed in contemporary reviews [D’antonio et al. 2008; Pin et al. 1995;
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Ferragutti et al. 2006]. For the purposes of this review, the remainder of the discussion
will emphasize the iGlu receptor sub-type, including NMDA and AMPA receptors.
NMDA receptor (NMDA-R) is an ionotropic glutamate receptor selectively
activated by the glutamate agonist NMDA. NMDA-R activation is unique in two
capacities: first, it is a ligand-gated channel requiring two ligand agonists for activation;
and second, its activation is voltage dependent. The ligand component of NMDA-R
activation requires binding to the agonist-binding site which has affinity for both
glutamate and aspartate (although aspartate does not stimulate receptors as strongly as
glutamate). An additional ligand required for activation of NMDA-R is the ‘co-agonist’,
glycine. Finally, NMDA-R activation requires membrane depolarization. At resting
membrane potential (approx. -65 mV) extracellular Mg2+ blocks NMDA-R ion channels.
Depolarization of the cell membrane by 20-30 mV causes Mg2+ ions to be released from
the channel, thus opening the ion channel [Ozben et al. 1998]. The final result of
NMDA-R activation is flow of Na+ and small amounts of Ca2+ ions into the cell, and K+
out of the cell [Dingledine et al. 1999; Liu et al. 2000].
AMPA receptor (AMPA-R), also known as quisqualate receptor, is a non-NMDA
type ionotropic glutamate receptor activated by both quisqualate and the glutamate
analog AMPA. As an ionotropic receptor, AMPA-R mediates fast synaptic transmission
within the CNS, and generates fast excitatory postsynaptic potentials (EPSP) [Purves et
al. 2004]. AMPA receptors are glutamate gated cation-selective channels permeable to
Na+ and K+, but are impermeable to Ca2+ [Stern-Bach et al. 2004]. Although impermeable
to Ca2+, AMPA receptors help activate mechanisms that result in the entry of Ca2+ into
neurons. The Ca2+ entry results from the AMPA-induced membrane depolarization
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which, by alleviating the Mg2+ block of the NMDA receptor, activate the NMDA
receptor with a subsequent influx of Ca2+. Further, the AMPA induced membrane
depolarization is large enough to activate voltage operated Ca2+ channels [Ozben et al.
1998]. Because AMPA-R activation requires only the presence of glutamate and no
membrane depolarization, AMPA receptors are more suited for relaying the faster
“on/off” excitatory signaling within the CNS [Gonzales et al. 1997].
Glutamate – Neurotoxicity in Cerebral Ischemia
Extracellular glutamate concentrations are significantly increased in ischemic
brain tissue [Park et al, 1988]. The increased extracellular concentration is a result of
enhanced release of the amino acid from neurons [Scatton et al. 1994] and decreased reuptake by surrounding neurons and glial cells [Dallas et al. 2007, Ozben et al. 1998].
During ischemia, oxygen-glucose deprivation depletes energy formation, resulting in
failure of essential energy-dependent membrane ion gradients. As ion pumps fail,
membrane ion gradients deteriorate, ion channels open, and most intracellular and
extracellular ions begin to equilibrate causing anoxic depolarization [Ozben et al. 1998].
Pre-synaptic depolarization opens voltage-sensitive calcium channels (VSCC) allowing
Ca+ to enter [Pulsinelli et al. 1992]. This increased calcium triggers release of excitatory
amino acids (EAA) including glutamate. Additionally, the loss of membrane ion
gradients also decreases glutamate uptake. The resulting uncontrolled increase in
extracellular glutamate concentration over-activates post synaptic NMDA and AMPA
receptors in a condition known as ‘excitotoxicity’. Excitotoxicity causes many
deleterious effects following ischemic injury including oxidative stress and brain edema.
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Glutamate is an underlying cause in ischemic injury and in the formation of brain
edema [Juurlink et al. 1997; Love et al. 1999; Brahma et al. 2000]. Glutamate-receptor
activation has been shown to cause edema in normoxic brain slices in vitro [Espanol et al.
1994; Brahma et al. 2000]. Glutamate receptor activation also has been found to
contribute to the initial swelling that accompanies anoxic depolarization in slices [Werth
et al. 1998]. Prior studies by Oh et al. 1991 indicate that NMDA antagonists can
decrease brain swelling in vivo [Oh et al. 1991]. More recent in vitro work by MacGregor
et al. [2003] found that blocking glutamate receptors with NMDA and AMPA/kainate
antagonists greatly attenuated tissue water gain after ischemic insult [MacGregor et al.
2003]. Although the exact mechanism remains unclear, these studies suggest glutamate
receptor activation is a significant factor in the formation of brain edema.
MacGregor et al. 2003 also established that both glutamate and ROS are
underlying factors in the formation of brain edema in an oxygen and glucose deprivation
model of cerebral tissue ischemia. Their study indicated that glutamate receptor
antagonists and antioxidants result in similar attenuation of tissue edema in slices. An
additional study indicated that a treatment cocktail containing both glutamate receptor
antagonist and antioxidant showed a greater attenuation of tissue edema than any single
treatment component [MacGregor et al. 2003].
Glutamate- Cell Volume Regulation
Glutamate is a significant factor mediating cell volume regulation. Release of
taurine is enhanced by glutamate receptor agonists under hypoosmotic conditions
[Menendez et al. 1990]. Saransaari et al. [1997] observed that ionotropic glutamate
receptor agonists NMDA, kainate and AMPA potentiated taurine release from
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hippocampal tissue. This observed enhancement of taurine release was inhibited by
treatment with glutamate receptor antagonists of each ionotropic receptor subtype
(NMDA, kainate, and AMPA). These results indicate that the effect of glutamate on
taurine efflux is receptor-mediated in this hippocampal model. NMDA is generally
considered the most powerful agonist of taurine release but AMPA may be the most
effective at lower glutamate concentrations [Magnusson et al. 1991; Saransaari et al.
1991, 1994, 1997]. Finally, Saransaari et al. [1997] also established that both NMDA and
AMPA receptors were involved in taurine release throughout the life span, while kainite
receptor-mediated release does not appear to function in adults. These early works of
Sarasaari et al. in 1991, 1994 and 1997 were seminal studies in that they linked glutamate
receptor activation with taurine release in hippocampal tissue.
More recent studies have established a significant role for glutamate receptors in
osmo-regulation [Morales et al. 2007; Uckerman et al. 2009]. A significant increase in
extra-synaptic glutamate concentrations is observed in response to hypoosmotic
treatments. Tissues exposed to combined AMPA and kainate receptor antagonist CNQX
show significantly decreased taurine release in response to hypoosmotic treatment
[Morales et al. 2007]. Uckerman et al. [2009] observed inhibition of osmotic glial cell
swelling that is mediated by glutamate receptor activation. These studies suggest that
hypoosmolarity facilitates glutamate release, which, acting on ionotropic glutamate
receptors, contributes to the osmo-regulatory response [Morales et al. 2007; Uckerman et
al. 2009].
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Glutamate-Summary
Glutamate plays multiple roles in the processes of ischemic injury and oxidative
stress, neuronal and glial swelling, and in the mediation of cell volume regulating
mechanisms in the CNS. Glutamate concentrations greatly increase as a result of tissue
ischemia and these elevated glutamate levels contribute to both tissue injury and the
formation of brain edema. In the presence of tissue swelling, glutamate has also been
observed to mediate cell volume regulating mechanisms. Contemporary studies have
uncovered some of the effects of glutamate in cell swelling and volume regulation in the
CNS. However, the specific role of different ionotropic glutamate receptors during brain
tissue swelling induced by oxidative stress remains largely unclear. In this present study I
will examine the role of ionotropic glutamate receptors, NMDA and AMPA, for
hippocampal tissue swelling and volume regulation during oxidative stress. These
experiments will elucidate the specific role of glutamate in cell volume regulation during
oxidatively-induced brain edema.

4. Summary of Background
The research presented in this background describes the tightly entangled
relationships between the processes of oxidative stress, cellular swelling, cell volume
regulation and glutamate signaling in the CNS.
•

Reactive Oxygen Species (ROS) - Brain edema following ischemia or ischemiareperfusion is associated with the production of reactive oxygen species and
consequent oxidative stress to brain tissue. Oxidative stress is a causative factor in
brain tissue swelling, although the specific mechanisms are not well understood.
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The specific aims of this project will elucidate a potential mechanism explaining
ROS-induced brain tissue edema in vivo.
•

Taurine - In response to swelling, brain slice preparations activate volume
regulating mechanisms which include a significant efflux of the endogenous
amino acid taurine. Acting as an organic osmolyte, taurine mobilization is an
essential component in regulatory volume decrease following cell swelling of
both neuronal and glial cells. Taurine efflux is facilitated by volume regulating
anion channels (VRAC) and ROS may directly or indirectly affect this membrane
pathway. This project will examine the effects of ROS on taurine efflux via
VRAC during volume regulation.

•

Glutamate - Extracellular glutamate concentrations increase greatly as a result of
tissue ischemia and elevated glutamate levels contribute to both tissue injury and
in the formation of brain edema. In the presence of tissue swelling, glutamate
plays a role as a signal for cell volume control mechanisms. However, the role of
specific ionotropic glutamate receptors during brain tissue swelling induced by
oxidative stress remains largely unclear. This project will examine the role of
ionotropic NMDA and AMPA receptors during hippocampal tissue swelling and
volume regulation induced by oxidative stress.

To gain a deeper understanding of the interactions between reactive oxygen species,
taurine efflux and glutamate action, this project will address the following issues: the
effect of oxidative stress on cell volume regulation mechanisms in brain tissue slices, the
role of VRAC channels for volume regulation during oxidatively induced swelling, and
finally, the role of glutamate on both brain tissue swelling and volume regulation during
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oxidative stress. In addressing these specific aims, our project will examine critical
components of the relationships between oxidative stress, glutamate signaling, tissue
swelling and cell volume regulation. Further, it will provide deeper insight into the
mechanisms responsible for ischemia induced brain edema leading to improved treatment
and recovery from these devastating pathological conditions.
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CHAPTER III
HYPOTHESIS AND SPECIFIC AIMS
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1. Rationale

Oxidative stress induces hippocampal tissue cell swelling via a glutamate
signaling pathway and increases taurine efflux via VRAC channels. Further, glutamate
plays a role in the signaling of volume regulation pathways in the CNS. As a result, we
have proposed the following mechanism for taurine efflux initiated by oxidative stress in
the hippocampus.

Ox. Stress

Activates Glut-R

Hippocampal Swelling

Taurine Efflux

VRAC Activation

Volume Regulation

Specific Aim I, will establish the role of taurine efflux for volume regulation during oxidative
stress. I will then examine the above proposed mechanism in two additional specific aims. In
Specific Aim II, importance of tissue swelling (IIa) and the role of VRAC channels (IIb) for
taurine release and volume regulation will be examined. In Specific Aim III I will evaluate the
function of NMDA and AMPA glutamate receptors for oxidative stress-induced tissue swelling
and volume regulation.
2. Specific Aim I
Specific Aim I establishes that taurine efflux enhances volume regulation during oxidative stress
in hippocampal tissue slices.
Specific Aim I: Experiments
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Experiment I: Taurine efflux from hippocampal slices will be measured during exposure
to hydrogen peroxide. Taurine contents of some slices will be modified by incubation and
perfusion of some slices with aCSF containing taurine. This treatment will restore taurine lost
during slice preparation to physiological levels. Other slices will be incubated and perfused with
aCSF without taurine.
3. Specific Aim II
In Specific Aim II we hypothesize that taurine efflux initiated by oxidative stress:
a. is mediated by volume-regulated anion channels (VRAC)
b.

is activated by cellular swelling.

Specific Aim II: Experiments
Experiment II.A. Hippocampal slices with physiological taurine content will be exposed
to hydrogen peroxide in the presence or absence of DCPIB, a specific inhibitor of VRAC
channels. Hippocampal tissue swelling and taurine release will be monitored in this experiment.
Experiment II.B. Hippocampal slices with physiological taurine content will be exposed
to hydrogen peroxide in isoosmotic aCSF (290 mOsm) or in aCSF containing mannitol to raise
osmolality to 350 mOsm. Hippocampal tissue swelling and taurine release will be monitored in
this experiment.
4. Specific Aim III
In Specific Aim III we hypothesize that taurine efflux initiated by oxidative stress is mediated by
a glutamate receptor pathway.
Specific Aim III: Experiments
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Experiment III: Hippocampal tissue slices prepared to have physiological or low taurine
contents will be exposed to hydrogen peroxide. For some slices, NMDA or AMPA receptors will
be inhibited with MK-801 or CNQX, respectively. Hippocampal tissue swelling and taurine
release (in slices with physiological taurine contents) will be monitored in this experiment.
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CHAPTER IV
MATERIAL AND METHODS
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1. Ethical Approval
All experiments described in the present study were performed in accordance with
protocols approved by the Wright State University Institutional Laboratory Animal Care
and Use Committee (IACUC). Anesthesia protocols approved for these experiments
conform to the recommendations of the Panel on Euthanasia of the American Veterinary
Medical Association. Protocols are in accordance with the National Institute of Health
Guide for the Care and Use of Laboratory Animals (NIH publications N0. 80-23) revised
1996.
2. Slice Preparation
Experimental studies were performed using an acute preparation of hippocampal
slices prepared from male Sprague-Dawley rats (250-400 g). Prior to experimentation,
animals were housed in a controlled environment facility located on the Wright State
University Campus, (25° C, 12-h light/dark cycle) with food and water available ad
libitum. Animals were transported to our facility on the day of use.
Animals were rapidly asphyxiated to apnea with halothane, and placed in a supine
position on a dissection table. The thoracic cavity was exposed and the animal was
perfused via the left cardiac ventricle using artificial cerebrospinal fluid (aCSF) bubbled
in 95% O2 consisting of: 124 mM NaCl, 3.5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 1
mM Na2HPO4, 26 mM NaHCO3, and 10 mM glucose. After perfusion of approximately
50 ml of aCSF over 1 min, animals were decapitated using a guillotine and the scalp was
cut along midline. The skull was opened along midline working from the caudal to rostral
direction. Using surgical rongeurs, skull fragments were removed exposing first the
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cerebellum, followed by the cerebral cortex. Upon full brain exposure, underlying cranial
nerves were severed and the cortex, midbrain and cerebellum were transferred rapidly to
a chilling solution consisting of frozen aCSF slush.
After 5-7 minutes, the cerebellum was removed from the midbrain, and the brain
hemisected into right and left hemispheres. Hippocampi then were dissected from the
brain hemispheres, and the middle one-third of each was sectioned into 400 µm slices
using a Mcllwain tissue slicer. Slices were cut transversely in a plane that preserved
Schaeffer collateral connections [Teyler et al, 1980]. Slices were incubated at room
temperature for at least 90 min in chamber bubbled with 95% O2 + 5% CO2. Solutions
were made on the day of the experiment. The aCSF solution used for incubation and
initial treatments was isoosmotic (290 mOsm). Osmolarity was adjusted by adding small
volumes of 3 M NaCl and confirmed using a vapor pressure osmometer (Wescor, Salt
Lake City, Utah).
3. Tissue Treatment and Perfusate Sampling
Tissue taurine content is lost during slice preparation [Kreismen et al, 2003]. To
examine the role taurine plays for volume regulation, our experimental protocol
examined hippocampal tissue slice preparations that were either taurine-repleted during
incubation and perfusion or were left depleted of taurine following preparation. Taurine
repleted slices were incubated at room temperature in the bubbler chamber with aCSF
containing 1 mM taurine, while taurine depleted slices were incubated in aCSF without
added taurine. After incubation, brain tissue slices were transferred to an interface-type
imaging chamber with oxygenated aCSF (2 ml/min) perfused at 35° ± 0.5 C.
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Generally the experimental time course started with 90 min perfusion in isosmotic
aCSF followed by 25 min perfusion with aCSF containing 2 mM H2O2. When drug
treatments were used, they were added to the perfusate beginning 15 min prior to H2O2
exposure. For experiments with taurine repleted slices, 1 mM taurine was added to the
aCSF during the initial 30 min of perfusion. The following 60 min period in taurine free
aCSF allowed complete efflux of exogenous taurine from the extracellular compartment.
Effluent perfusate samples were collected in 2 min fractions for analysis of amino acid
efflux. In these experiments, control and drug studies were performed on the same day
with slices from the same animal.
4. Slice Imaging
An intrinsic optical signal (IOS) was used as an indirect measure of tissue
volume. IOS has been used to measure brain tissue volume changes in both osmotically
and excitotoxically stressed brain tissue slices [Andrew et al. 1999]. Hippocampal tissue
slices were trans-luminated with white light from a quartz-halogen source with a voltageregulated power supply, and observed with a stereo microscope (model SMZ-2, Nikon,
Melville, NY) During perfusion, images of the entire hippocampal slice were recorded
every 60 sec using a standard video camera with fixed gain. Using the Image J program,
we designated the striatum radiatum of the CA1 area of the hippocampus as our selected
region of interest for measuring changes in tissue IOS throughout our experiments. The
mean intensity for the region of interest was recorded into a text file, and then transferred
to Windows Excel (Microsoft) software for graphing and analysis.

67

5. Taurine Concentration Analysis
Perfusate solution was collected in 2 min fractions throughout incubation of the
slices on the imaging stage. Solutions were frozen at -70 °C, and 1 ml aliquots were
lypholized and then resuspended in 0.1 ml of 0.6 M HClO4. Upon termination of the
experiment, hippocampal tissue slices were fixed in 1 ml of 0.6 M HClO4 and sonicated.
This suspension was then centrifuged at 10,000 x g for 1 min. Amino acids were
determined in the concentrated perfusate samples and in the supernatant from the
hippocampal slices by HPLC [Olson and Li 2000].
Taurine concentrations were determined on a high-performance liquid
chromatograph (HPLC) system with a 5 µm C18 reverse phase column (250 x 4.6 mm)
and fluorimetric detection with 340 nm excitation and emission cut-off at 420 nm. Precolumn derivitization was performed with o-phthaldialdhyde-2-mercaptoethonal-borate
reagent. After a 120 sec reaction period, the reaction was terminated with iodoacetamide
and the solution injected into the HPLC column 30 sec later. The mobile phase was
composed of 50 mM sodium phosphate and 38% methanol (pH = 5.65).
6. Statistics
Analyses were performed using one-way repeated measure ANOVA followed by
Dunnett’s test for post hoc comparisons. Time dependent changes in IOS were evaluated
with linear and non-linear regression. Data are given as means ±SE. Analysis was
performed using GBStat program software (Dynamic Microsystems, 1997). Curve fits
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were performed using pClamp 8 software (Axon Instruments, Sunnyvale, California). A
level of p< 0.05 was considered critical for assigning statistical significance.
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CHAPTER V
RESULTS
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1. Specific Aim I
In Specific Aim I we examined the role of taurine in volume regulation during
oxidative stress by exposing hippocampal slice preparations to H2O2 and measuring both
volume change and taurine concentrations in the perfusate. We measured the effects of
H2O2 exposure on slices incubated in taurine supplemented aCSF (previously defined as
“taurine repleted”), and on slices incubated in aCSF alone (previously defined as “taurine
depleted”).
Taurine enhances volume regulation in hippocampal slices during oxidative stress
Hippocampal slices prepared by incubation in normal aCSF without taurine have
reduced taurine contents compared with the hippocampus in situ [Kreisman et al, 2003].
Slices prepared in this manner demonstrated a significant increase in IOS (3.27 ± 1.25%
at t = 25 min, n = 5) during exposure to 2 mM H2O2, indicating a statistically significant
increase in volume. In contrast, slices incubated with aCSF supplemented with 1 mM
taurine have normal taurine contents during experimentation and showed little swelling
throughout the period of oxidative stress (1.08 ± 0.61% at t = 25 min, n = 12) [Figure 3]
and [Table 1]. By multiple linear regression, the rate of change in IOS (±SE) was 0.064 ±
0.012 percent/min in taurine repleted slices while the rate in taurine depleted slices was
0.137 ± 0.019 percent/min. The difference between these rates (0.073 ± 0.022
percent/min) was statistically significant. Taurine depleted slices exhibited nondetectable levels of taurine in the perfusate prior to and during H2O2 exposure (data not
shown). In contrast, slices incubated in 1 mM taurine had measurable taurine in the
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Figure 3
Volume change in the hippocampus during oxidative stress. Hippocampal slices were
perfused with aCSF containing 2 mM H2O2 from t = 0 min to the end of the data sampling period
shown. Values are the mean ± SEM for 5-12 independent experiments. The intrinsic optical
signal (IOS) was calculated for areas of the stratum radiatum in the CA1 region of the
hippocampus. Slices incubated with normal aCSF during preparation (solid symbols, n = 5)
showed a significant increase in IOS during exposure to H2O2 while slices incubated with 1 mM
taurine (hollow symbols, n = 12) showed little change in IOS. Regression lines were calculated
from the relative intensity values between 0 min and 25 min. * indicates values which are
significantly different from the average of five baseline measurements determined at 1 min
intervals prior to H2O2 treatment.
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Table 1
Summary of the effect of H2O2 on volume of taurine depleted and taurine repleted
hippocampal slices. Changes in the intrinsic optical signal (IOS) were measured in the stratum
radiatum of the CA1 region and determined after 25 min of H2O2 exposure. These represent time
points which resulted in peak responses observed in control slices as shown in Figure 3. Values
are the mean ± SEM. * Indicates values which are significantly different from baseline
measurements determined prior to H2O2 treatment.
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Table 1
Volume Change: H2O2 effect on

Volume Change: H2O2 effect on

taurine depleted hippocampal

taurine repleted hippocampal

slices (% change in IOS at 25

slices (% change in IOS at 25

min)

min)

Control

3.27 ± 1.25% * (n = 5)

1.08 ±0.61% (n = 12)

CNQX

1.19 ± 0.39% (n = 6)

2.54 ± 0.78%* (n = 5)

MK-801

1.93 ± 0.26%* (n = 6)

5.01 ± 2.36%* (n = 5)

DCPIB

N/A

3.05 ± 1.12%* (n = 4)
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perfusate and demonstrated an increase in taurine perfusate concentration of 335 ± 178%
(n = 3) during the period of H2O2 exposure [Figure 4].
2. Specific Aim II
In Specific Aim II we investigated whether taurine efflux during oxidative stress
is regulated via VRAC in this hippocampal tissue model by monitoring both volume and
taurine efflux in the presence and absence of a VRAC inhibitor. We further examined
whether H2O2 could elicit taurine efflux from the tissue in the absence of net swelling.
Taurine efflux in hippocampal slices requires VRAC activity
To measure the role of VRAC during H2O2 exposure, hippocampal tissues were
treated with the VRAC inhibitor, 20 µM DCPIB [Abdullaev et al, 2006]. We observed
that taurine repleted slices, treated with DCPIB demonstrated a significant increase in
IOS of +3.05 ± 1.12% (n = 4) upon exposure to H2O2 over 25 min [Figure 5]. Further, by
multiple linear regression we calculated a rate of IOS change during H2O2 exposure of
0.064 (± 0.012) percent/min in taurine repleted slices without drug treatment and a slope
of 0.129 (± 0.004) percent/min in taurine repleted slices treated with DCPIB. The
difference in these rates was 0.065 (± 0.005) percent/min) indicating a statistically larger
rate of increase IOS in DCPIB treated slices. The observed increase in IOS indicates
hippocampal tissue swelling occurs during H2O2 exposure with VRAC inhibition.
We observed a transient increase in taurine efflux upon exposure to DCPIB in
normal aCSF. However, the rate of taurine efflux returned to a new stable baseline prior
to H2O2 exposure [Figure 6]. After returning to this baseline, no increase in taurine efflux
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Figure 4
Taurine efflux from hippocampal slices during oxidative stress. Hippocampal slices were
perfused with aCSF containing 2 mM H2O2 from t = 0 min to the end of the data sampling period
shown. Values are the mean ± SEM. Taurine concentrations were measured in the effluent of the
aCSF that perfused hippocampal slices prepared to maintain normal taurine contents. The taurine
concentration in the aCSF perfusate increased significantly (335 ± 178%, n = 3) at the start of
H2O2 exposure and remained elevated for 10 min. * indicates values which are significantly
different from the baseline measurements determined prior to H2O2 treatment.
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Figure 5
The role of VRAC on volume change in hippocampal slices during oxidative stress. Taurine
repleted hippocampal slices were perfused with aCSF containing DCPIB (20 µM ) beginning at
time t = -15 min and then perfused with aCSF containing 2 mM H2O2 from t = 0 min to the end of
the data sampling period shown. Values are the mean ± SEM for independent experiments. The
intrinsic optical signal (IOS) was calculated for areas of the stratum radiatum in the CA1 region
of the hippocampus. Slices treated with DCPIB (solid symbols, n = 4) showed a significant
increase in IOS during exposure to H2O2 over 25 min, while slices incubated with 1 mM taurine
(hollow symbols) alone showed little change in IOS (1.08 ± 0.61%, n = 12). Regression lines
were calculated from the relative intensity values between 0 min and 25 min. * indicates values
which are significantly different from the average of five baseline measurements determined at 1
min intervals prior to H2O2 treatment.
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Figure 6
Transient taurine efflux from hippocampal slices during treatment with VRAC antagonist.
Hippocampal slices were prepared to maintain normal taurine contents prior to DCPIB (20 µM)
exposure at t = 0. Values are the mean ± SEM. Taurine concentrations were measured in the
effluent aCSF prior to and during DCPIB exposure. The taurine concentration in the aCSF
perfusate increased significantly (453.42 ± 272.65%, n = 4) within 5 min DCPIB exposure, but
gradually returned within 15 min to a stable value not significantly greater than the baseline
measured prior to DCPIB exposure.* indicates values which are significantly different from five
baseline measurements determined at 1 min intervals prior to DCPIB treatment.
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occurred during exposure to oxidative stress. In fact, taurine efflux actually decreased
during the H2O2 exposure in the presence of DCPIB (-59.8 ± 7.0%, n = 4) [Figure 7].
We investigated the effect of oxidative stress on taurine efflux from hippocampal
tissue slices during exposure to hyperosmotic conditions. The osmolarity of the aCSF
was increased to 350 mOsm with the addition of mannitol for 15 min prior to and
throughout treatment with 2 mM H2O2 in the perfusate. Mannitol treatment significantly
and rapidly decreased IOS within the first 10 min of exposure in both controls, and in
slices exposed to H2O2 after 15 min [Figure 8]. A subsequent slow trend toward baseline
volume was also observed in both control slices and slices exposed to H2O2 after 15 min.
To access the effect of H2O2 against controls in these hyperosmotic conditions, slope
analysis was calculated to determine if there was a change in rate of recovery toward
baseline as a result of H2O2 exposure. In this slope comparison, the graph does show a
slight inflection in the rate of recovery toward baseline in the H2O2 slices compared to
controls. However, statistical comparison of these data sets indicates that after the initial
15 min of H2O2 exposure, there is no difference in the slopes between the remaining 15
min and 30 min of H2O2 exposure. Taurine efflux remained unchanged throughout the
duration of the experiment for slices treated with H2O2 and for control slices [Figure 9].
3. Specific Aim III
In specific aim III we examined the role of glutamate signaling in volume
regulation by measuring volume and taurine efflux from hippocampal slices exposed to
either NMDA or AMPA receptor blockers.
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Figure 7
Taurine efflux from hippocampal slices treated with VRAC antagonist during oxidative
stress. Hippocampal slices were prepared to maintain normal taurine contents prior to DCPIB
(20 µM) exposure at t = -15 min. Slices then were perfused with aCSF containing aCSF plus 2
mM H2O2 from t = 0 min to the end of the data sampling period shown. Values are the mean ±
SEM for 4 independent experiments. The taurine concentration in the aCSF perfusate decreased
significantly after 10 min of H2O2 exposure and remained decreased throughout the sampling
period. * indicates values which are significantly different from the baseline measurements
determined prior to H2O2 treatment.

84

Taurine Efflux (% of Baseline)

Figure 7
800%

600%

400%

H2O2

200%
*

*

*

*

*

*

*

*

*

0%
-5

0

5

10

Time (min)

85

15

20

25

Figure 8
Volume changes in hippocampal slices in hypertonic media during oxidative stress.
Hippocampal slices were prepared to maintain normal taurine contents. Slices were then perfused
with 350 mOsm mannitol aCSF from t = 0 to the end of the data sampling period shown. Some
slices (hollow symbols, n = 6) were perfused with aCSF containing 2 mM H2O2 from t = 15,
while other control slices (solid symbols, n = 5) were not exposed to H2O2. Values are mean ±
SEM of independent experiments. Reduction in IOS signal expresses the change in IOS at each
time point normalized to the maximal decrease in volume during mannitol exposure. Regression
lines were calculated from the mean values of the relative intensity values between t = 15 min and
30 min but are shown over longer time periods for clarity. The slopes of these regression lines are
not significantly different for slices with or without H2O2 exposure.
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Figure 9
Taurine efflux from hippocampal slices in hypertonic media during oxidative stress
Hippocampal slices were prepared with 1 mM taurine to maintain normal taurine contents. Slices
(n = 5) were then perfused with aCSF made hypertonic (350 mOsm) by adding mannitol
beginning at t = 0, and then perfused with this same solution plus 2 mM H2O2 from t = 15 min
until the end of the data sampling period shown. There are no statistically significant changes in
taurine efflux observed either after the mannitol treatment, or after exposure to H2O2.
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AMPA receptors and NMDA receptors are coupled to hippocampal swelling during
oxidative stress in taurine depleted slices
It has been established that activation of NMDA receptors causes brain tissue
edema in vitro [Brahma et al, 2000]. As a positive control, we exposed our hippocampal
tissue slices to NMDA (100 µM) and observed a significant increase in IOS (+11.78 ±
1.95%, n = 6) within 5 minutes of NMDA exposure and then a gradual trend toward
baseline [Figure 10].
Next, hippocampal slices were exposed to an inhibitor of either NMDA-receptors
(10 µM MK-801) or AMPA-receptors (25 µM CNQX) [Macgregor et al. 2003] during
H2O2 exposure. In taurine depleted slices, a significant change in IOS was observed after
25 minutes when 2 mM H2O2 was added to the perfusate in the presence of CNQX
(+1.19 ± 0.39%, n = 6) [Figure 11]. By multiple linear regression we calculated a rate of
change in IOS of 0.137 (± 0.019) percent/min in taurine depleted slices without CNQX
treatment and a rate of 0.031 (± 0.010) percent/min in taurine depleted slices treated with
CNQX during H2O2 exposure. The difference in these rates (-0.105 ± 0.015 percent/min)
was statistically significant.
Taurine depleted slices treated with MK-801 during to H2O2 exposure also
showed a significant increase in IOS of 1.93 ± 0.26% after 25 min (n = 6) [Figure 11].
Multiple linear regression revealed a rate of change in IOS of 0.085 (± 0.0101)
percent/min during H2O2 exposure in the presence of MK-801. This rate of change in IOS
was smaller than that determined for control slices by -0.051 (± 0.015) percent/min,
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Figure 10
Volume change in hippocampal slices exposed to NMDA. Taurine depleted hippocampal slices
were perfused in aCSF for 45 min prior to exposure to NMDA (100 µM) t = 0 min. NMDA
induces significant swelling (11.78 ± 1.95%, n = 6) within the first 5 min of exposure followed by
a gradual decrease toward the initial baseline. * indicates values which are significantly different
from the average of five baseline measurements determined at 1 min intervals prior to NMDA
treatment.
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Figure 11
Glutamate receptors and tissue swelling in hippocampal slices during oxidative stress.
Taurine depleted hippocampal slices were treated with CNQX (25 µM, n = 6) or MK-801 (10
µM, n = 6) beginning at t = -15 min. Control slices received no drug treatment. Slices then were
perfused with aCSF containing the same drug plus 2 mM H2O2 from t = 0 min to the end of the
data sampling period shown. Values are the mean ± SEM. The intrinsic optical signal (IOS) was
calculated for areas of the stratum radiatum in the CA1 region of the hippocampus. Control slices
(n = 4) demonstrated significant changes in IOS throughout the period of H2O2 exposure.
Regression lines were calculated from the mean values of the relative intensity values between 0
min and 25 min. * indicates values which are significantly different from the average of five
baseline measurements determined at 1 min intervals prior to H2O2 treatment.
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indicating a statistically significant difference compared with control slices. These data
are summarized in Figure 12.
Glutamate signaling is coupled to volume regulation during oxidative stress
To examine the role glutamate signaling plays for oxidative stress-induced swelling and
volume regulation, taurine repleted hippocampal slices were treated with either an
NMDA receptor blocker (10 µM MK-801) or an AMPA receptor blocker (25 µM
CNQX) prior to and during exposure to 2 mM H2O2. In these studies, both volume and
taurine efflux were measured throughout the experiment. Similar to what was observed
during inhibition of VRAC with DCPIB, during exposure to CNQX or MK-801
hippocampal slices demonstrated an initial increase efflux of taurine [Figure 13 & Figure
14]. However, this response was variable with some slices in each treatment group
exhibiting a large amount of taurine efflux after drug exposure while others exhibited
almost no change in taurine efflux. After 15 min of continued drug exposure, taurine
efflux levels recovered on average to a constant baseline level which was not statistically
different than the rate measured prior to drug exposure. Slices were then treated with
H2O2 in the presence of the glutamate receptor blocker. Changes in IOS were determined
for 25 min of H2O2 exposure and rates of taurine efflux are reported after 10 min of H2O2
exposure as this typically represents time of maximal efflux. In addition, by reporting
mean taurine efflux values 10 min after H2O2 exposure we present the more immediate
effect of H2O2 on taurine efflux in the slices. As indicated in results of specific aim I,
taurine repleted slices had an increase in IOS of 1.08 ± 0.61% after 25 min and an
increase in taurine efflux of +335.88 ± 178.12% after 10 min of H2O2 exposure [Figures
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Figure 12
Summary of treatment results for glutamate receptor agonists and antagonists: Taurine
depleted control hippocampal slices without drug treatments increased IOS by over 3% after 25
min of H2O2 exposure. NMDA treatment caused an increase in IOS to a maximum of nearly
12%. In the presence of the NMDA-R antagonists MK-801 or CNQX, the H2O2-induced increase
in IOS was less than that observed in control slices. Values are the mean ± SEM for individual
experiemnts. ** indicates values which are significantly different from the average of five
baseline measurements determined at 1 min intervals prior to H2O2 treatment.
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Figure 13
Transient taurine efflux from hippocampal slices during exposure to AMPA antagonist.
Hippocampal slices were prepared to maintain normal taurine contents prior to CNQX (25 µM, n
= 4) exposure at t = 0. Values are the mean ± SEM for 4 independent experiments. Taurine
concentrations were measured in the effluent aCSF perfusate. The taurine concentration in the
aCSF perfusate increased significantly to a maximum within 5 min CNQX exposure, but
gradually returned to a stable value within 15 min. This value was not significantly greater than
the baseline prior to H2O2 exposure.* indicates values which are significantly different from the
baseline measurements determined prior to CNQX treatment.
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Figure 14
Transient taurine efflux from hippocampal slices during NMDA antagonist. Hippocampal
slices were prepared with 1 mM taurine to maintain normal taurine contents prior to MK-801 (10
µM, n = 4) exposure at t = 0. Values are the mean ± SEM for 4 independent studies. Taurine
concentrations were measured in the effluent of the aCSF perfusate. The taurine concentration in
the aCSF perfusate showed upward trend peaking at an increase of 168% ± 230.5% above
baseline, but this increase did not reach statistically significant change during the 15 min of MK801 exposure.
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3 & 4, Table 2]. Taurine repleted slices exposed to H2O2 in the presence of MK-801
exhibited a significantly greater increase in IOS (+5.01 ± 2.36%, n = 5), indicating a
larger degree of swelling compared with control slices [Figure 15]. By multiple linear
regression the rate of change in IOS of 0.064 (± 0.012) percent/min in taurine repleted
control slices increased to 0.213 (± 0.023) percent/min in taurine repleted slices exposed
to MK-801. The difference in these rates of change in IOS (0.149 ± 0.027 percent/min)
was statistically significant. MK-801-treated slices also exhibited a net decrease in
taurine efflux during H2O2 exposure (43.31 ± 13.43%, n = 4) [Figure 16, Table 2].
When taurine repleted slices were exposed to H2O2 in the presence of CNQX,
they also demonstrated a significant increase in IOS after 25 min (2.54 ± 0.78%, n = 5)
[Figure 15]. By multiple linear regression, the rate of change in IOS was 0.115 (± 0.017)
percent/min in taurine repleted slices treated with CNQX during H2O2exposure. The
difference in rate compared with that of control slices was 0.051 (± 0.020) percent/min
and was statistically significant. Further, slices treated with CNQX exhibited decreased
taurine efflux rate compared with controls, (-58.06 ± 16.23%, n = 4) [Figure 16, Table 2].
In contrast to the significant variability in taurine efflux observed in slices as a result of
the drug exposures, all slices responded similarly in regards to taurine efflux after
exposure to H2O2 regardless of the initial drug-induced efflux.
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Table 2
Summary of drug effects on tissue swelling and taurine efflux from the hippocampus during
oxidative stress. All experiments were performed using taurine repleted hippocampal slices .
Changes in IOS measured in the stratum radiatum of the CA1 region and the relative rate of
taurine efflux were determined after 25 min and 10 min of H2O2 exposure, respectively. These
represent time points which resulted in peak responses observed in control slices with no drug
treatment. Values are the mean ± SEM. * Indicates values which are significantly different from
baseline measurements determined prior to H2O2 treatment. ++ indicates a statistically significant
difference between the change in IOS for slices receiving a drug treatment compared with that
measured in control slices.
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Table 2
Change in IOS following 25

Change in taurine efflux

min of H2O2 exposure in

following 10 min of H2O2

hippocampal slices

exposure in hippocampal
slices

Control

1.08 ± 0.61% (n = 12)

335.88 ± 178.12%* (n = 3)

CNQX

2.54 ± 0.78%*++ (n = 5)

-58.06 ± 16.23%* (n = 4)

MK-801

5.01 ± 2.36%*++ (n = 5)

-43.31 ± 13.43% (n = 4)

DCPIB

3.05 ± 1.12%*++ (n = 4)

-59.8 ± 7.0%* (n = 4)
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Figure 15
The role of AMPA and NMDA receptors in volume changes during oxidative stress.
Taurine repleted hippocampal slices were treated with CNQX (25 µM) or MK-801 (10 µM)
beginning at t = -15 min. Control slices received no drug treatment. All slices were perfused with
aCSF containing 2 mM H2O2 from t = 0 min to the end of the data sampling period shown.
Values are the mean ± SEM independent measurements. IOS was calculated for areas of the
stratum radiatum in the CA1 region of the hippocampus. Slices treated with CNQX (triangle dark
symbols, n = 5) or MK-801 (round dark symbols, n = 5) showed a significantly greater increase in
IOS during exposure to H2O2, compared with control slices (hollow symbols, n = 12). Regression
lines were calculated from the relative intensity values between 0 min and 25 min. * indicates
values which are significantly different from the average of five baseline measurements
determined at 1 min intervals prior to H2O2 treatment.
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Figure 16
NMDA and AMPA receptors in taurine efflux during oxidative stress. Taurine repleted
hippocampal slices were perfused with MK-801 (10 µM) and CNQX (25 µM) starting at t = -15
min. Slices then were perfused with aCSF containing 2 mM H2O2 from t = 0 min to the end of
the data sampling period shown. Values are the mean ± SEM of four independent experiments.
Taurine concentrations were measured in the effluent of the aCSF perfusate and are expressed
relative to baseline measurements determined prior to H2O2 exposure. The taurine concentration
in the aCSF perfusate in CNQX samples (triangle dark symbols, n = 4) decreased significantly at
the start of H2O2 exposure, and remained significantly decreased throughout the sampling period.
The taurine concentration in the aCSF perfusate with MK-801 (solid round symbols, n = 4)
showed a gradual downward trend during H2O2 exposure, but this change was not statistically
significantly from the concentration measured prior to H2O2 exposure. * indicates values which
are significantly different from baseline measurements determined prior to H2O2 treatment.
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CHAPTER VI
DISCUSSION
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This study illuminates several mechanisms involved in swelling and volume
regulation in the hippocampus exposed to oxidative stress. We first demonstrate that
taurine is necessary for volume regulation during oxidative stress and that the taurine
efflux is regulated via VRAC to control swelling. We demonstrate that increased taurine
efflux during oxidative stress is due to tissue swelling, rather than direct activation of
VRAC channels by H2O2. Finally, the results of our experiments indicate that activation
of glutamate receptors is coupled to hippocampal swelling, but also plays a significant
role in volume regulation during oxidative stress [Tucker et al. 2010]. This discussion
will elucidate the results of this study and provide a better understanding of the
relationships between the processes of oxidative stress, cell swelling, glutamate signaling
and volume regulation.

1. Taurine is necessary for brain slice volume regulation during oxidative stress
We examined the role of taurine in swelling and volume regulation during
oxidative stress by exposing hippocampal slice preparations to H2O2. Taurine’s role in cell
volume regulation is well established in the CNS. Cell studies have indicated that taurine
plays a significant role in volume regulation in both astrocytes and neurons [Kimelberg et
al. 1990; Vitarella et al. 1994; Pasantes-Morales et al. 1994]. In brain tissue, in situ and in
vitro studies indicate that taurine is the most important osmotically active organic
molecule involved in volume regulation during both hypoosmotic hyponatremia, and
hyperosmotic dehydration [Verbalis et al. 1991; Bedford et al. 1993]. Additional studies
have shown that exposure of brain tissue to hypoosmotic conditions causes a reduction in
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brain taurine content [Kimelberg et al. 1995], and that taurine efflux is enhanced in both
cerebral cortical slices and hippocampal tissue slices exposed to hypoosmotic conditions
[Franco et al. 2000; Law et al. 1994]. Thus, our present understanding of osmoticallyinduced swelling and volume regulation via loss of taurine is well documented. However,
what is less established is whether the mechanisms behind oxidatively induced swelling
and volume regulation under isoosmotic conditions are the same as those in
hypoosmotically induced swelling and whether taurine plays the same role in enhancing
volume regulation during oxidative stress as it does in other causes of tissue swelling.
The results of our studies indicate that when hippocampal tissue taurine content is
diminished, there is a reduced or absent volume regulatory response to swelling induced
by oxidative stress. Further, our results indicate that restoration of physiological levels of
taurine enhances volume regulation in response to oxidatively induced swelling. These
results are consistent with studies by Kreisman et al. [2003] who observed that restoration
of hippocampal tissue taurine to physiological levels enhanced RVD in response to
hypoosmotic swelling. With our present data we confirm that, similar to slices exposed to
hypoosmotic conditions, the release of taurine from intracellular stores is critical for isoosmotic volume regulation of the hippocampus exposed to oxidative stress.

2. Taurine efflux during oxidative stress is mediated by VRAC
It is well established that hypoosmotically induced taurine release is mediated via
VRAC [Jackson et al. 1996; Okada et al. 2001]. Studies show VRAC-mediated taurine
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release in cultured hippocampal astrocytes, hippocampal neurons, hippocampal slices,
and in rat cortex [Li et al. 2008; Li et al. 2004; Kriesman et al. 2003; Stutzin et al. 2006].
While numerous cell and tissue studies demonstrate VRAC-mediated taurine efflux in the
hypoosmotic swelling model, there are limited studies regarding the role of VRAC in
volume control during oxidatively induced swelling [Haskew-Layton et al. 2005]. Some
of the evidence that taurine efflux is mediated via VRAC largely stems from cultured
neuronal and glial cells, which show that swelling-activated taurine fluxes are inhibited
by a variety of VRAC blockers [Stutzin et al. 2006]. In our study we inhibited oxidative
stress-induced taurine efflux by the VRAC antagonist DCPIB. DCPIB is a selective
VRAC blocker found to block VRAC currents in several cell lines, but not endogenous or
heterologously expressed ClC-1, ClC-2, ClC-4, ClC-5, CFTR, or calcium-activated
Cl− channels [Decher et al. 2001]. In our experiments, tissue swelling was observed
during oxidative stress in the presence of DCPIB, indicating that VRAC activity is
necessary for the volume regulatory response during oxidative stress. These results also
indicate VRAC-mediated taurine efflux is as significant for attenuating tissue swelling
induced by oxidative stress as it is during hypoosmotic exposure.
In this work we also address whether the increase in taurine release observed
during oxidative stress is due to cell swelling or by direct activation of VRAC by H2O2.
Studies have shown that ROS may play a significant role as an intracellular messenger
regulating RVD [Lambert et al. 2003]. Others also have established that H2O2 potentiated
the swelling-induced taurine efflux in hypoosmotic medium [Stutzin et al. 2006]. Further,
a recent study found that VRAC may be activated or positively modulated by ROS,
particularly H2O2, in microglial cells [Harrigan et al. 2008; Varela et al. 2004]. In order to
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establish whether ROS activates VRAC independently of swelling, the tissue slices in
these experiments were exposed to a hypertonic treatment of mannitol prior to, and
throughout, H2O2 exposure. With this experimental model, we were able to maintain
hippocampal tissue in a non-swollen status as we monitored taurine efflux after H2O2
exposure. Our results show that taurine efflux was not increased during oxidative stress
after pre-treatment with hyperosmolar aCSF. This suggests, in this non-swollen state,
H2O2 is not acting directly on VRAC to induce taurine efflux. These results appear to
contradict the studies of Lambert et al. [2002] and Stutzin et al. [2006] which both
suggest a direct activation of taurine release via H2O2. While these studies observed
significant taurine release after H2O2 exposure, neither study accounted for H2O2-induced
swelling, which also would be expected to lead to taurine release. In this respect these
studies are limited because cell volume was not measured, and thus, it is not clear
whether taurine efflux was induced directly by H2O2 exposure, or indirectly by cell
swelling. By monitoring and maintaining the tissue in an osmotically ‘non-swollen’ state
during H2O2 exposure, our experiment removes the swelling component in the system.
Our model provides a more accurate measure of the effect of H2O2 in these tissue slices
in the absence of swelling.
During hyperosmotic treatment, H2O2 did not cause additional swelling. Figure 8
shows a slight deflection in the recovery line shortly after the application of H2O2 leading
to a slower recovery to baseline compared to controls. This may indicate that oxidative
stress has an effect on the RVI process. Currently, there is limited literature indicating
that cell shrinkage inhibits taurine release, or that cell shrinkage alters the activation of
VRAC. Tissues which have been osmotically shrunk prior to H2O2 exposure, as we did in
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our experiments, may have activated regulatory volume increase (RVI) mechanisms
which could potentially affect taurine release regardless of H2O2 exposure. This
represents a limitation in our use of mannitol in studying the effects of H2O2 in the ‘nonswollen’ environment. It is not unreasonable to propose that taurine release is inactivated
as a counter-regulatory mechanism when cells are osmotically shrunken and undergoing
RVI. There is an absence of studies that have examined the effects of H2O2 exposure in
volume regulation in a model that simultaneously limits swelling. Future experimentation
is necessary in both cell culture and tissues to isolate the direct effects of H2O2 in the
absence of swelling.

3. AMPA and NMDA receptors are coupled to hippocampal swelling during
oxidative stress
Glutamate receptor inhibitors have been shown to significantly diminish swelling
in hippocampal tissue slices exposed to oxidative stress [MacGregor et al. 2003];
however, the individual contributions of NMDA and AMPA during H2O2 have not been
elucidated. Further, glutamate-receptor activation has been shown to cause edema in
brain slices in vitro [Brahma et al. 2000] and to contribute to the initial cell swelling
observed during anoxic depolarization in slices [Werth et al. 1998; MacGregor et al.
2003]. We also have witnessed hippocampal tissue swelling after treatment with NMDA
(100 µM), presumably mediated by glutamate receptors. The mechanisms by which
glutamate may contribute to brain edema are many, from the initial Na+ entry and
consequent swelling that accompanies ionotropic glutamate-receptor activation, [Werth et
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al. 1998] to the activation of a number of secondary processes, including mitochondrial
dysfunction, Ca2+ loading, and ROS production [Macgregor et al. 2003; Prehn et al.
1998; Nichols et al. 2000].
Our data suggest that both AMPA, and to a lesser extent NMDA sub-types of
ionotropic glutamate receptors contribute to hippocampal swelling induced by oxidative
stress in taurine-depleted slices. Consistent with data from MacGregor et al. 2003, work
on the role of glutamate receptors in in vitro ischemia models, our results indicate a
significant role of glutamate-receptor activation in the formation of brain tissue edema
during oxidative stress. The greater swelling effect of the AMPA receptor may be
explained by the effect of AMPA on membrane potential and thus, its interaction with the
NMDA pathway. Because NMDA activation requires the simultaneous presence of both
agonist and membrane depolarization, any inhibition of AMPA-stimulated depolarization
will have secondary effects on NMDA receptor activation. In this regard, blocking an
AMPA receptor has a two-fold effect on tissue swelling, blocking both AMPA itself and
secondarily inhibiting NMDA via inhibition of membrane depolarization. MacGregor et
al. [2003] showed that a cocktail of NMDA antagonist, AMPA antagonist, mitochondrial
permeability antagonist, and antioxidant was more effective in attenuating edema than
any single treatment alone. Their study indicated a significant, but not exclusive role for
glutamate in ischemia-induced brain tissue swelling [Macgregor et al. 2003]. Our data
further indicates a more prominent role of AMPA in swelling during oxidative stress.
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4. NMDA-receptor signaling is coupled to volume regulation during oxidative
stress
Ionotropic glutamate receptor agonists can effectively enhance taurine release.
The effects of these drugs have been shown to be glutamate receptor-mediated in adult
mouse hippocampal slices under isoosmotic conditions [Saransaari et al. 1997]. Further,
works by Morales et al. [2007] established that glutamate receptors are involved in
stimulating taurine efflux from the substantia nigra exposed to hypoosmotic conditions.
To date, however, there are limited studies that address the specific role of glutamate
receptors on taurine efflux in tissue swollen by oxidative stress. To effectively study
volume regulation of normal hippocampal tissue, taurine concentrations were restored to
physiological levels prior to H2O2 exposure [Kreisman et al. 2003].
Our results indicate that when taurine-repleted slices were exposed to H2O2 in the
presence of the NMDA antagonist MK-801, significant swelling occurred. In these same
slices the rate of taurine efflux was not altered by oxidative stress. Since taurine efflux
was not increased during the period of oxidative stress, we conclude that activation of
NMDA receptors is necessary for effective volume regulation via organic osmolyte
efflux in the presence of H2O2. Recent studies indicate that synaptic NMDA receptor
activity boosts intrinsic anti-oxidant defenses in CNS [Papadia et al. 2008]. In the
presence of NMDA receptor antagonist during oxidative stress, CNS tissue has a
diminished capacity to defend itself against the deleterious effects precipitated by
reactive oxygen species. Thus, the role of NMDA receptor activation in swelling and
volume regulation during oxidative stress may be multi-faceted. First, our data suggest
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that NMDA receptor activation is necessary for proper volume regulation and taurine
efflux during H2O2-induced swelling. Second, activation of NMDA receptors enhances
anti-oxidant defenses, which could provide neuro-protection inhibiting swelling caused
by of H2O2-induced injury.

5. AMPA-receptor signaling is coupled to volume regulation during oxidative
stress
Because swelling induced by oxidative stress was markedly diminished by CNQX
in taurine-depleted slices, the role that AMPA receptors may play for volume regulation
resulting from increased taurine efflux cannot be evaluated definitively. However, when
taurine-treated slices were exposed to H2O2 in the presence of CNQX, significant
swelling was again observed compared to control slices, and the rate of taurine efflux was
decreased. The decrease of taurine efflux upon H2O2 exposure in the presence of CNQX
suggests that AMPA receptors are also necessary for effective volume regulation
mediated by loss of intracellular taurine.
The decrease in H2O2-induced taurine release in the presence of CNQX is
consistent with previous studies that reported an attenuated taurine response to
hypoosmotic swelling in tissues treated with an AMPA-kainate glutamate receptor
antagonist [Saransaari et al. 1997]. This implies that glutamatergic mechanisms involved
in volume regulation are similar during osmotically and oxidatively-induced swelling.
We propose that oxidatively-induced swelling facilitates localized glutamate release,
which, acting on ionotropic glutamate receptors, increases the taurine osmo-regulatory
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response. This mechanism is similar to a proposal by Morales et al. [2007], for
hypoosmotically induced taurine release in the substantia nigra.

6. Glutamate and purinergic receptor-mediated volume regulation – a possible
mechanism for glutamate effects on cell volume during oxidative stress
Our results indicate that glutamate receptor activation is involved in both tissue
swelling and volume regulation in the hippocampus during oxidative stress. A
mechanism linking glutamate signaling to cell volume regulation has been proposed by
Uckermann et al. 2006. In a study of osmotic glial cell swelling in rat retinal cells,
Uckermann et al. 2006 observed that glutamate had an inhibitory affect on osmotic glial
cell swelling, and that the mechanism involved a purinergic signaling pathway. They
proposed a neuron-to-glia glutamate signaling cascade that inhibited osmotic glial cell
swelling in post-ischemic retinal cells exposed to hypoosmotic conditions. The study
showed that neuronal glutamate activated mGluRs on glial cells, causing a release of
ATP and a signaling cascade resulting in the efflux of K+ and Cl-. The observed release
of ions was accompanied by water efflux, resulting in regulatory volume decrease.
Although this study does not indicate which specific cells were swelling and which were
releasing taurine, our results suggest that glutamate-mediated volume regulation may
occur in the hippocampus. This may involve a neuron-to-glia signaling pathway in tissue
swelling induced by oxidative stress in a mechanism similar to that proposed in
Uckerman et al. 2006.
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ATP has been proposed as an autocrine signaling molecule in volume regulatory
mechanisms in many cell types [Wang et al.1996; Darby et al. 2003]. ATP is released
from a variety of cells upon hypoosmotically induced swelling [Mitchell et al. 2001;
Sabirov et al. 2001; Phillis et al. 2002] with an increase in concentration large enough to
activate purinergic receptors [North et al. 2000]. Purinergic receptors have been coupled
to activation of anion channels in many cell types, including hippocampal neurons and in
astrocytes [Li et al. 2004; Mongin et al. 2002]. Extracellular ATP has also been found to
activate chloride and taurine conductances in cultured astrocytes [Li et al. 2004]. Finally,
purinergic receptor activation has been observed to activate anion channels (VRAC)
established in this and previous studies to allow release of taurine during swelling
induced by oxidative stress. With this increasing insight into the role of ATP in cell
volume regulation, future works are needed to broaden our understanding in this area.
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CHAPTER VII
LIMITATIONS AND
FUTURE WORKS
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There were several limitations within this research project. The first limitation
was the use H2O2 as our source for ROS in the induction of oxidative stress. H2O2
exposure was chosen because it commonly increases during oxidative stress in vivo, and
is commonly used for induction of experimental oxidative stress in vitro [Pellmar et al.
1991]. H2O2 is both the product of the catalyzation of reactive superoxide radicals by
SOD and is, itself, easily converted to the highly reactive and destructive hydroxyl
radical. However, H2O2 represents only one of many classes of ROS that can elicit
oxidative stress and has also been shown to act as a signaling molecule. Another
limitation of the study was the use of mannitol in some experiments to ensure the tissue
remains in a ‘non-swollen’ state during oxidative stress. The significant decrease in
tissue volume induced by this treatment may induce RVI mechanisms. Finally, the
unexpected observation of increased taurine efflux elicited by the application of drugs is
another limitation. This observed increase in taurine efflux was over a range of drug
classes that includes glutamate receptor antagonists and chloride channel antagonists and
different vehicles used to prepare drug stock solutions. In all cases, the rate of taurine
efflux returned to a baseline not significantly larger than that prior to drug exposure.
However, because of the neuro-inhibitory properties of taurine, this increased efflux may
alter the subsequent response to H2O2 observed in our experiments.
Future works may define more specifically the mechanisms mediating glutamate
receptor activated tissue swelling and volume regulation. Our experiments focused
exclusively on the ionotropic glutamate receptors AMPA and NMDA and did not
examine the possible role of metabotropic glutamate receptors. Uckermann et al. [2006]
reported that glutaminergic metabotropic receptor activation may mediate cell volume
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regulation. In addition, while we did not differentiate neuron and glial responses to
oxidative stress the volume regulatory mechanism may differ and warrant examination of
cell-specific responses. These studies also are limited by the use of IOS as an index of
the volume changes rather than directly measuring tissue volume. Although IOS is an
established method of measuring tissue volume, future works could also include optical
assessments of cell volume or wet weight/dry weight analysis of water content [Brahma
et al. 2000].
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CHAPTER VIII
CONCLUSION
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Our results indicate that the release of taurine from intracellular stores is critical
for isoosmotic volume regulation of the hippocampus exposed to oxidative stress.
Further, taurine is lost from hippocampal cells during oxidative stress via the volume
activated anion channel (VRAC). Glutamate AMPA receptors, and to a lesser extent
NMDA receptors are coupled to hippocampal swelling during oxidative stress. Further,
volume regulation of the hippocampus also is regulated, in part, by glutamate signalling
via NMDA and AMPA receptors. Establishing the importance of taurine mobilization
during swelling induced by oxidative stress and defining a significant role for glutamate
receptors in swelling and volume regulation is an important step in understanding the
cellular response to cytotoxic brain edema. Future work is needed to further our
understanding of the response and adaptation of brain cells to edema leading to improved
treatments and recovery from these devastating pathological conditions.
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